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ABSTRACT
This dissertation discusses the development of plasmonic and X-ray luminescence
nanoparticles (~100 nm) to use in bioimaging and sensing applications. The nanoparticles
have interesting optical properties compared to their atomic levels and bulk materials.
The optical properties of nanomaterials can be controlled by changing size, shape, crystal
structure, etc. Also, they have a large surface area that can be functionalized with
biomolecules. Therefore, the optical properties and biofunctionalized nanomaterials are
useful in biomedical applications such as targeted drug delivery, bioimaging, and sensing.
The overall theme is to use nanoparticles with interesting optical properties compared to
their atomic levels and bulk materials to understand and control size/shape-dependent
optical properties and crystallinity. Here, we discuss nanomaterials' optical properties and
biofunctionalization in three sections, 1) size/shape-dependent optical properties of
plasmonic nanoparticles, which we develop a simple and robust mechanical approach to
prepare plasmonic nanoparticle arrays, 2) X-ray optical luminescence of X-ray
luminescence nanoparticles which depends on crystal defects and amount of dopants by
synthesizing them and enhancing their intensity to use them in high-resolution imaging,
3) biofunctionalization of gold and X-ray luminescence nanoparticles to develop
immunoassays.
Chapter two describes the development of a simple, mechanical approach to
preparing plasmonic nanoparticle arrays and transferring them onto a thin film.
Plasmonic nanoparticles can absorb and scatter visible range light depending on their
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size, shape, and environment, and unlike fluorescence dyes, they do not photo-bleach.
Plasmonic nanoparticles and array of nanoparticles have many applications including in
bioimaging and sensing. The current methods to develop nanoparticle arrays and transfer
them onto thin films are complex, time-consuming, and expensive. Here, we report a
simple technique to generate patterns of gold and silver nanoparticles with controlled
shape and shape-dependent optical properties. The pressure was applied to nanoparticles
on a glass slide to convert nanospheres (diameter ~ 90 nm) to nanodiscs (diameter ~180
nm). Metal stamps and glucose deposits were placed on nanoparticles before applying
pressure to generate patterns. The change in nanoparticle shape causes their localized
surface plasmon resonance wavelength to red-shift. Also, we developed a method to
remove undeformed nanoparticles using scotch tape and transform nanoparticle patterns
into a flexible polymer film.
Like plasmonic nanoparticles, X-ray luminescence nanophosphors can be used as
an optical contrast agent in biomedical imaging and optical biosensors. They generate
visible light through tissue when irradiated with X-rays. However, the sensitivity of these
applications depends on the intensity of emitted visible light, and it is important to
investigate methods to enhance its intensity. Herein, we describe the synthesis of X-ray
scintillating NaGdF4:Eu and Tb nanophosphors via co-precipitate and hydrothermal
methods, enhancing X-ray excited optical luminescence. The brightest particles were
obtained using hydrothermal synthesis, and thermal annealing enhanced X-ray
luminescence intensity. However, annealing above 600 °C changes the chemical
structure to NaGd9Si6O26:Eu, which results in a shift in the X-ray luminescence spectra.
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Further, we demonstrated that the particles generate light through tissue and can be
selectively excited using a focused X-ray source for imaging and spectroscopy.
The fourth chapter brings plasmonic and X-ray luminescence particles together to
develop immunoassays. Here, we describe a design and development of a gold
nanoparticles-based lateral flow assay (LFA) to detect SARS-CoV-2 antibodies in human
saliva and a proof of concept to develop an immunoassay using gold nanoparticles and Xray luminescence nanoparticles. Gold and X-ray luminescence particles were
functionalized with receptor binding domain protein and human anti-spike IgG,
respectively. Our preliminary studies show the ability to develop the LFA to detect
SARS-CoV-2 antibodies in human saliva, an immunoassay using RBD functionalized
gold nanoparticles, and anti-spike IgG functionalized Gadolinium oxysulfide
microparticles. The X-ray luminescence decreases by a factor of 1.8 due to light
absorption when attaching gold nanoparticles to Gadolinium oxysulfide microparticles.
This can be developed as an implantable immunoassay to quantify biomarkers in vivo
locally and continuously.
Chapter five includes a separate study that is not based on nanoparticles-based
bioimaging and sensing. However, it discusses a behavioral analysis to discover and
understand the X-ray stimulated behavior of Caenorhabditis elegans.
Chapter six provides a conclusion and discusses possible future work for each
chapter.

iv

DEDICATION
I dedicate this work to the free education in Sri Lanka, my parents, Sarath
Ranasinghe and Ranjanie Abeyrathne, my husband Mohan M. Abeysekera, extended
family, and friends for their unconditional love and support throughout this journey.

v

ACKNOWLEDGMENTS
I would like to acknowledge the guidance, support, and patience of my Ph.D.
advisor, Dr. Jeffrey Anker, throughout my Ph.D. journey. He has always been there to
answer my questions, listen to my concerns and help me learn and communicate
scientific thoughts. I wish to thank all the people whose assistance was a milestone in
completing this project, especially my Ph.D. committee, Drs. George Chumanov, Joseph
Kolis, and Jason D. McNeill.
This research would not have been possible without the collaborative support of
Drs. Appara Rao, Dept. of Physics, Delphine Dean, Congyu Peng, Dept. of
Bioengineering, Clemson University, Mark Bolding University of Alabama at
Birmingham, and other group members of Anker lab, and the insightful conversations
that we had during the project meetings overall these years. Specifically, Fathima Ameer
trained me on the plasmonic nanoparticle deformation project. The C. elegans
experiments were performed with Kellin Cannon from the University of Alabama at
Birmingham, Dr. Congyu Peng, Dept of IIT Ctr Medical Devices/Sensor, for advising
and ordering chemicals for developing LFA.
I wish to show my gratitude to the wonderful staff at Clemson Light Imaging
Facility (CLIF) and the electron microscope facility (EM Lab) for training me in many
light and electron microscopes, Rakesh Sachdeva for training me on several instruments
in the chemistry department, Colin McMillen for helping me with powder-XRD, and the
physics and bioengineering departments for allowing me to use their instruments.

vi

I wish to acknowledge my family's support and great love; my hard-working
parents who strived to provide me and my brother with the best educational opportunities,
my brother (Nimesha Ranasinghe) and his family for taking me to visit beautiful places in
the USA, my cousins (Prabha Ranasinghe and Sidath Wijesinghe) who came to Clemson
University before me helped me to settle in a foreign land, My husband, who always
thinks my happiness before his and gives me enormous support throughout this journey.
These research projects were based upon work supported by NIBIB of the
National Institutes of Health under award number 1R21EB019709-01A1 and NIGMS of
the National Institutes of Health under award number 5P20GM103444-07 outreach
activities based on the results were supported by NSF CHE1255535, NSF Track II
EPSCoR OIA-1632881 for the synthesis by the NIH NIBIB R01EB026646 for the X-ray
luminescence imaging and P30 GM131959 for the electron microscopy, South Carolina
COVID fund for lateral flow assay project.

vii

TABLE OF CONTENTS
Page
ABSTRACT................................................................................................................. ii
DEDICATION................................................................................................................ v
ACKNOWLEDGMENTS..............................................................................................vi
TABLE OF CONTENTS............................................................................................. viii
LIST OF FIGURES....................................................................................................... xi
CHAPTER ONE
INTRODUCTION........................................................................................................... 1
1.1. Plasmonic Nanoparticles for Imaging and Sensing Applications ..................... 3
1.2. X-ray Luminescence Nanoparticles for Imaging and Sensing Applications .... 7
1.3. Applications of Plasmonic and X-ray Luminescence particles: Developing
immunosensors ........................................................................................................... 15
1.4. Radiation-Induced Behavior of Caenorhabditis elegans ................................ 16
1.5. List of Publications ......................................................................................... 18
1.6. References ....................................................................................................... 18
CHAPTER TWO
IMPRESSIVELY PRINTING PATTERNS OF GOLD AND SILVER
NANOPARTICLES ...................................................................................................... 29
2.1. Abstract ........................................................................................................... 29
2.2. Introduction ..................................................................................................... 30
2.3. Methods........................................................................................................... 32
2.3.1. Methods and Instrumentation ................................................................... 32
2.3.2. Poly(4-vinylpyridine) functionalization of glass substrate ....................... 33
2.3.3. AuNPs and AgNPs Synthesis ................................................................... 34
2.3.4. Deposition of nanoparticles on PVP functionalized ITO glass slides ...... 35
2.3.5. Mechanical deformation of nanoparticles ................................................. 36
2.3.6. Dark field optical imaging ........................................................................ 36
2.3.7. Hyperspectral darkfield microscopy ......................................................... 37
2.3.8. Atomic force microscopy (AFM) ............................................................. 37
2.4. Results and Discussion ................................................................................... 38

viii

2.4.1. Manual and force-controlled nanoparticle deformation ........................... 38
2.4.2. Stamping deformation pattern................................................................... 47
2.5. Conclusions ..................................................................................................... 62
2.6. Acknowledgment ............................................................................................ 62
2.7. References ....................................................................................................... 63
CHAPTER THREE
X-RAY EXCITED LUMINESCENCE SPECTROSCOPY AND IMAGING WITH
NaGdF4:Eu AND Tb........................................................................................................ 71
3.1. Abstract ........................................................................................................... 71
3.2. Introduction ..................................................................................................... 72
3.3. Methods........................................................................................................... 74
3.3.1. NaGdF4:Eu and NaGdF4:Tb nanoparticle synthesis ................................. 74
3.3.2. Silica coating NaGdF4:Eu and Tb nanoparticles ...................................... 76
3.3.3. Annealing NaGdF4:Eu nanoparticles ........................................................ 76
3.3.4. Functionalization of NaGdF4:Eu@SiO2 with biotin ................................. 76
3.3.5. Dark field optical imaging capillaries filled with NaGdF4:Eu through tissue
77
3.3.6. MR imaging of NaGdF4:Eu and Tb .......................................................... 78
3.3.7. Transmission electron microscopy ........................................................... 79
3.3.8. Powder X-ray diffraction (XRD) .............................................................. 79
3.3.9. X-ray excited optical luminescence (XEOL) spectroscopy ...................... 79
3.3.10.
ICP-OES metal analysis ........................................................................ 80
3.3.11.
Thermal analysis: TGA/DSC ................................................................ 80
3.4. Results and Discussion ................................................................................... 80
3.4.1. NaGdF4:Eu and NaGdF4:Tb nanoparticle synthesis ................................. 81
3.4.2. Inductive coupled plasma-optical emission spectroscopy (ICP-OES) metal
analysis 87
3.4.3. Silica-coating NaGdF4:Eu and Tb nanophosphors ................................... 89
3.4.4. Thermal analysis ....................................................................................... 90
3.4.5. Annealing NaGdF4:Eu nanophosphors ..................................................... 92
3.4.6. Biotin functionalized NaGdF4:Eu@SiO2 .................................................. 96
3.4.7. X-ray excited optical luminescence spectroscopy and imaging of capillaries
filled with NaGdF4:Eu through tissue ..................................................................... 97
3.4.8. MR imaging of NaGdF4:Eu and Tb ........................................................ 101
3.5. Conclusions ................................................................................................... 103
3.6. Acknowledgments......................................................................................... 103
3.7. References ..................................................................................................... 104
CHAPTER FOUR

ix

FUNCTIONALIZING RADIODENSE PARTICLES AND DEVELOPING
IMMUNOASSAYS TO DETECT SARS-CoV-2 ANTIBODIES................................113
4.1. Abstract ......................................................................................................... 113
4.2. Introduction ................................................................................................... 114
4.3. Methods......................................................................................................... 116
4.3.1. Designing and developing an LFA to detect SARS-CoV-2 antibodies (Proof
of concept) ............................................................................................................ 116
4.3.2. Functionalizing gold NPs with SARS-CoV-2 receptor-binding domain
(RBD) protein ....................................................................................................... 118
4.3.3. Functionalizing Eu doped gadolinium oxysulfide (Gd2O2S:Eu/ GOS:Eu, 2.5
µm) microparticles with human anti-spike IgG antibodies .................................. 119
4.3.4. ray excited optical luminescence (XEOL) spectroscopy ........................ 120
4.4. Results and Discussion ................................................................................. 121
4.4.1. Designing and developing an LFA to detect SARS-CoV-2 antibodies (Proof
of concept) ............................................................................................................ 121
4.4.2. Functionalizing gold NPs with SARS-CoV-2 receptor-binding domain
(RBD) protein ....................................................................................................... 124
4.4.3. Developing an x-ray luminescence immunoassay to detect SARS-CoV-2
antibodies (Proof of concept) ................................................................................ 126
4.5. Conclusions ................................................................................................... 127
4.6. Acknowledgments......................................................................................... 128
4.7. References ..................................................................................................... 128
CHAPTER FIVE
X-RAY STIMULATED EGG EJECTION OF C. ELEGANS .....................................134
5.1. Abstract ......................................................................................................... 134
5.2. Introduction ................................................................................................... 135
5.3. Methods......................................................................................................... 139
5.3.1. Growing, maintaining, and preparing C. elegans plates in the laboratory139
5.3.2. Experiment setup .................................................................................... 141
5.3.3. Egg ejection experiments ........................................................................ 142
5.4. Results and discussion .................................................................................. 143
5.5. Conclusions ................................................................................................... 147
5.6. Acknowledgments......................................................................................... 147
5.7. Reference ...................................................................................................... 147
CHAPTER SIX
SUMMARY AND FUTURE WORK........................................................................... 150
6.1.
6.2.

Introduction ................................................................................................... 150
Impressively printing patterns of gold and silver nanoparticles ................... 151

x

6.3.

X-ray excited luminescence spectroscopy and imaging with NaGdF4:Eu and Tb
154
6.4. Functionalizing radiodense particles and developing immunoassays to detect
SARS-CoV-2 antibodies ........................................................................................... 160
6.5. Conclusion .................................................................................................... 161
APPENDICES................................................................................................................164

LIST OF FIGURES

Figure

Page

Figure 1. 1: Size comparison of nanoparticles of interest to some biological components.
Modified from ref. 1. .......................................................................................................... 2
Figure 1. 2: (A) Schematic diagram illustrating a localized surface plasmon resonance.
(B) real and imaginary parts of the dielectric function of silver as a function of
wavelength. Taken with permission of ref. 6 (C) Calculated extinction spectra of gold
nanorods with varying aspect ratios. Taken with permission of ref. 3 ............................... 5
Figure 2. 1: Characterization of (A) 97 nm diameter AgNPs, (B) 72 nm diameter AuNPs
(B), and (C) 94 nm diameter AuNPs using UV-vis spectroscopy (A1, B1, and C1), and
scanning electron microscopy (A2, B2, and C2). The scale bar in each SEM image is 300
nm. Taken with permission of ref 1. ................................................................................. 39
Figure 2. 2: (A) Photograph of AuNPs on a glass slide being manually deformed with a
glass stir rod. A glass substrate coated with AuNPs is placed on a slide holder fixed to the
optical bench to hold it steady, and a glass stirring rod rolls over the AuNPs to flatten
them. (B) A rolling pin, comprising of a ¼″ glass tube with a metal pin through it, is held
in a mechanical test system fixture and rolled over particles deposited on a PVP
functionalized ITO glass substrate. (C) Dark field microscopy image showing both
undeformed AuNP (bottom, green) and deformed AuNPs (top, red) on a PVP
functionalized glass substrate. 4X zoom in images of (D) deformed and (E) undeformed
AuNPs. Representative dark field single AuNP scattering spectra from (F) deformed and
(G) undeformed AuNPs. The squared AuNPs in figures (D) and (E) produced the spectra
shown in (F) and (G), respectively. Scale bar is 20 µm. Spectra are offset for clarity.
Taken with permission of ref 1. ........................................................................................ 40
Figure 2. 3: Photograph showing the deformation technique employed in this study. The
rolling pin was placed on one end of the slide to begin with. A mechanical force was
applied by the ESM 303 as the glass tube was rolled over the length of the glass substrate

xi

10 times. The applied force was varied from 0 to 50 N, and a constant rolling speed of
500 µm/s was used in each experiment. The glass tube was cleaned several times using
acetone and distilled water prior to use. Taken with permission of ref 1. ........................ 41
Figure 2. 4: Dark field microscope image showing both deformed (top-red) and
undeformed (bottom-blue) regions of Ag NPs on a glass/ITO slide. Taken with
permission of ref 1. ........................................................................................................... 42
Figure 2. 5: (Left) SEM images showing effect of applied load (A1) 0 N, (B1) 30 N, and
(C1) 50 N on deformation of AuNPs. All images have the same magnification (Scale bar
is 300 nm). Histograms on the right of each SEM image show particle diameter
distributions for (A2) undeformed and (B2, C2) deformed AuNPs. The sample
preparation and SEM imaging procedure are described in the Experimental Section. The
inset numbers show estimated mean diameter and uncertainty from a Gaussian fit. (D1)
Average dark field single nanoparticle scattering spectra of one hundred undeformed and
deformed AuNPs as a function of applied load (0, 1, 3, 5, 8, 10, 30, 50 N). The spectra
are scaled to the same maximum intensity. (D2) Experimental data on the evolution of
LSPR peak position, before and after deformation, as a function of applied load.
Figure 2.6 shows a comparison with our previous AgNP study. Taken with permission of
ref 1. .................................................................................................................................. 44
Figure 2. 6: Average dark field single nanoparticle scattering spectra of un-deformed and
deformed (A) AgNPs and(C) AuNPs as a function of applied load. The spectra are scaled
to the same maximum intensity. Experimental data on the evolution of LSPR peak
position, before and after deformation of (B) AgNPs and (D) AuNPs as a function of
applied load. Panels A and B are adapted from reference.31 Taken with permission of ref
1......................................................................................................................................... 45
Figure 2. 7: (A) Dark field microscope image of patterned/deformed Ag NPs by placing
TEM grid on NPs and mechanically pressing them. (B) Dark field microscope images
(Zoomed in) of location 1,2 and 3 by placing polarizer at 0 (zero) and 90 degrees of
angle. NPs marked using yellow color boxes show polarization dependent scattering
properties. Some of the NPs at location 3 shows shape and orientation dependent
scattering. Taken with permission of ref 1........................................................................ 46
Figure 2. 8: Photographs of glass slide coated with AgNPs, with stamp patterns formed
by manually pressing either at TEM grid or VACCO grid onto the slide with a rolling
pin. The blue color is a result of light scattering by the undeformed particles, and the red
regions represent scattered light by the deformed particles. The stamping and imaging
were performed by volunteers during the Upstate EMAG!NE public education outreach
event in Greenville, South Carolina. The vertical streaks are the scratched marks caused
by the rolling rod on the microscope slide. Taken with permission of ref 1. ................... 48
Figure 2. 9: Patterning with TEM grid pattern. (i-iii) Schematic illustration of the
principle of the patterning technique. The patterning technique involves three steps: (i)
Deposition of nanoparticles on PVP functionalized glass slides, (ii) Patterning of selected
nanoparticles via mechanical deformation using a TEM grid as a stamp (not drawn to

xii

scale), and (iii) Lift-off of TEM grid from sample surface, which leaves deformed
nanoparticles in shape of the TEM-grid pattern. Images of Au (middle row) and Ag
(bottom row) NPs deformed under a copper TEM-grid pattern. (A1, B1) Hyperspectral
dark field images and (A2, A3, B2, B3) SEM images. Both undeformed and deformed
regions were marked using a dashed line. (A4, B4) Representative average dark field
scattering spectrum from un-deformed and deformed Au and Ag NPs regions,
respectively. Taken with permission of ref 1. ................................................................... 51
Figure 2. 10: (A) SEM image showing both deformed (right to dotted line) and
undeformed (left to dotted line) regions of Ag NPs on an ITO slide. The number of
particles per unit area is unchanged before and after deformation (~10 particles/µm2).
(B1-B2) AFM images of AgNPs deformed under a copper TEM grid pattern. Contact
AFM was used to map the profiles of patterned AgNPs on PVP-functionalized ITO glass
substrates by applying 50 N load. Partly deformed individual Ag nanoparticles. (C1) 2D
and (C2) 3D AFM images showing boundary between deformed and undeformed AgNPs.
(C3) Zoom in image showing a single nanoparticle that was partly deformed. Taken with
permission of ref 1. ........................................................................................................... 52
Figure 2. 11: Histograms of the average AgNPs height (A) before and (B) after
deforming using TEM grid. All AFM height measurements were obtained based on more
than at least 150 particles. Taken with permission of ref 1. ............................................. 53
Figure 2. 12: (A1) Optical profiler image of VACCO grid showing parallel streaks, (A2)
zoom in image of (A1). (A3) 3D AFM image showing surface roughness (ridges and
grooves) of VACCO grid. Dark field microscope images of deformed regions of (B1)
AuNPs and (C1) AgNPs. Zoom in images of (B2) AuNPs and (C2) AgNPs from B1 and
C1 showing printed parallel streaks and surface roughness (green (B2) and blue (C2)
areas in deformed regions are due to grooves of VACCO grid). 3D AFM images of (B2)
AuNPs and (C2) AgNPs deformed using the hexagonal patterned VACCO grid. Taken
with permission of ref 1. ................................................................................................... 54
Figure 2. 13: High resolution AFM images in (A) 2D and (B) 3D. Areas within the white
circles show the deformed nanoparticles caused by the ridges in the hexagonal stamp (see
Figure 4). Taken with permission of ref 1. ....................................................................... 55
Figure 2. 14: (A) Hyperspectral dark field image showing protected region of Ag NPs
around the glucose deposit and deformed region away from the deposit. (B) Dark field
single nanoparticle scattering spectra of undeformed (blue region), partially deformed
(green and yellow regions) and deformed (red region) NPs corresponding to image (A).
(C) Scanning electron microscopic image of patterned Ag NPs. ..................................... 56
Figure 2. 15: i-iii, Schematic illustration of the removal of undeformed nanoparticles
using adhesive tape. (i) Mechanically deformed nanoparticles; (ii) applying adhesive tape
on the patterned glass substrate to peel-off undeformed NPs; (iii) pattern of deformed pa
particles left on the glass slide. (A1-A3) Hyperspectral dark field images of AuNPs
deformed with a TEM grid; (B1-B3) hyperspectral dark field images of AgNPs deformed
with a TEM grid. (A1, B1) Pattern before removing undeformed particles; (A2, B2)

xiii

pattern after removal of undeformed NPs with adhesive tape; (A3, B3) 40X zoom in
images of patterned AuNPs and Ag NPs from A2 and C3. Taken with permission of ref 1.
........................................................................................................................................... 57
Figure 2. 16: Transferring AgNPs to flexible polymer films. (A1) First ContactTM clear
polymer polymerized into a thin-film on a glass slide. (A2) Peeling off, and (A3)
stretching of the clear thin-film. Dark field microscope images (100 x oil, immersion) of
(B1) patterned and undeformed Ag NPs on a glass slide, (B2) patterned and undeformed
Ag NPs remaining on glass slide after removing NPs using a thin film. Taken with
permission of ref 1. ........................................................................................................... 59
Figure 2. 17:A i-A iii, Schematic illustration of the transfer of NPs onto a clear polymerfilm. (A i) Patterned and undeformed NPs on glass slide; (A ii) applying Clear First
Contact polymer, letting it dry and peeling off (NPs transferred onto the polymer-film);
(A iii) NPs remained on the glass slide. Dark field microscope images of patterned and
undeformed NPs on (B i) glass slide and (B ii) undeformed NPs on polymer-film, (B iii)
remaining NPs on the glass slide. Dark field microscope images of patterned and
undeformed NPs on (C i) glass slide and (C ii) on polymer-film, (C iii) remaining NPs on
the glass slide. Dark field microscope images of patterned NPs on (D i) glass slide after
removing undeformed NPs and (D ii) patterned NPs on polymer-film, (D iii) remaining
NPs on the glass slide. Taken with permission of ref 1. ................................................... 61
Figure 2. 18: Photograph showing the deformation technique employed in this study. The
rolling pin was placed on one end of the slide to begin with. A mechanical force was
applied by the ESM 303 as the glass tube was rolled over the length of the glass substrate
10 times. The applied force was varied from 0 to 50 N, and a constant rolling speed of
500 µm/s was used in each experiment. The glass tube was cleaned several times using
acetone and distilled water prior to use.A ....................................................................... 125
Figure 3. 1: (A) Schematic illustration of nanophosphors synthesis according to coprecipitate method. (i) Mixture of Gd(NO3)3 and Eu(NO3)3 or Tb(NO3)3, (ii) Ln3+–
citrate3− complex appears as a clear solution, (iii) formation of NaGdF4:Ln3+
nanophosphors. Zoom out TEM images of (B1) NaGdF4:Eu and (C1) NaGdF4:Tb
nanophosphors. Zoom in TEM images of (B2) NaGdF4:Eu and (C2) NaGdF4:Tb
nanophosphors. Histograms of the average diameter of (B3) NaGdF4:Eu and (C3)
NaGdF4:Tb. Powder XRD pattern compared to PDF cards 27-0699 of (B4) NaGdF4:Eu
and (C4) NaGdF4:Tb. Taken with permission of ref 1. .................................................... 82
Figure 3. 2: TEM images of NaGdF4 doped with (i) 0.1%, (ii) 1%,(iii) 15%,(iv) 20%,(v)
100% Eu synthesized using the co-precipitate method. Scale bar is equal to 100 nm. XRD
patterns of (A) Eu and (B) Tb-doped NaGdF4 (Gd: dopant molar ratio= 1: 0.1, 1, 15, 20,
100%). XRD data were collected using single-crystal XRD as an alternative of powder
XRD. PDF card is 27-0699. Taken with permission of ref 1. .......................................... 83
Figure 3. 3: X-ray excited optical luminescence (XEOL) of (A) NaGdF4:Eu and (B)
NaGdF4:Tb nanophosphors. Eu and Tb dopant fraction (mol% added to reagents vs. Gd)
of NaGdF4 nanophosphors varied from 0.1% to 100%. X-ray luminescence intensities of

xiv

nanophosphors were normalized to the 620 nm peak intensity from commercial GOS:Eu
and Tb microphosphors. Spectra have been vertically displaced for ease of comparison.
Taken with permission of ref 1. ........................................................................................ 85
Figure 3. 4: (A) Schematic illustration of nanophosphors synthesis according to coprecipitate method. (i) Mixture of Gd(NO3)3 and Eu(NO3)3 or Tb(NO3)3, (ii) Ln3+–
citrate3− complex appears as a clear solution, (iii) formation of NaGdF4:Ln3+
nanophosphors, (iv) hydrothermally treated NaGdF4:Ln3+ nanophosphors. TEM images
of hydrothermally treated (B1) NaGdF4:Eu and (B2) NaGdF4:Tb nanophosphors. (B3)
Powder XRD pattern compared to PDF cards 27-0699 of NaGdF4:Eu and NaGdF4:Tb.
Taken with permission of ref 1. ........................................................................................ 86
Figure 3. 5: TEM images of NaGdF4 doped with (i) 0.1%, (ii) 1%, (iii) 15%,(iv) 20%,(v)
100% Eu synthesized using the hydrothermal method. Scale bar is equal to 100 nm. XRD
patterns of (A) Eu- and (B) Tb-doped NaGdF4 (Gd: dopant molar ratio= 1: 0.1, 1, 15, 20,
100%). XRD data were collected using single-crystal XRD as an alternative of powder
XRD. PDF card is 27-0699. Taken with permission of ref 1. .......................................... 86
Figure 3. 6: XEOL of hydrothermally treated (A) NaGdF4:Eu and (B) NaGdF4:Tb
nanophosphor. Mol fraction of Eu and Tb dopant vs. Gd in regent mixture varied from
0.1% to 100%. X-ray luminescence intensities of nanophosphors were normalized to the
height of 620 nm peak of commercial GOS:Eu and Tb microparticles. Spectra have been
vertically displaced by adding a baseline for ease of comparison. Taken with permission
of ref 1. .............................................................................................................................. 87
Figure 3. 7: Metal composition of nanophosphors calculated using ICP-OES
measurements. The graph of percent metal ratio of nanophosphor vs. percent molar
fraction of dopant added of NaGdF4:Eu synthesized by (A1) co-precipitate and (A2)
hydrothermal methods and NaGdF4:Tb synthesized by (B1) co-precipitate and (B2)
hydrothermal methods. Note, the amount of Tb in NaGdF4:0.1%Tb was not calculated as
it is lower than the limit of detection of the instrument. Take with permission of ref 1. . 88
Figure 3. 8: (A) Schematic illustration of nanoparticle coating with silica. (i)
NaGdF4:Ln3+ nanophosphors, (ii) silica-coated NaGdF4:Ln3+ nanoparticles. (B1) TEM
images of silica-coated NaGdF4 nanophosphors Eu-doped. (B2) Histograms of the
diameter of silica-coated NaGdF4:Ln3+ nanoparticles. (B1) TEM images of silica-coated
NaGdF4 nanophosphors Eu-doped. (B2) Histograms of the diameter of silica-coated
NaGdF4:Eu. Take with permission of ref 1. ..................................................................... 89
Figure 3. 9: XEOL spectra of silica-coated (A) NaGdF4:Eu and (B) NaGdF4:Tb compared
to NaGdF4:Eu and NaGdF4:Tb synthesized using co-precipitate method. Taken with
permission of ref 1. ........................................................................................................... 90
Figure 3. 10:(A) TGA and (B) DSC of NaGdF4:Eu and NaGdF4:Tb nanophosphors
synthesized using co-precipitate and hydrothermal methods and NaGdF4:Eu@SiO2.
Taken with permission of ref 1. ........................................................................................ 91

xv

Figure 3. 11: TGA thermograms showing (A) weight loss of synthesized nanophosphors,
(B) derivative of weight loss (C) DSC of sodium citrate and PVP. Taken with permission
of ref 1. .............................................................................................................................. 92
Figure 3. 12: (A) SEM image and (B) XEOL of NaGdF4:Eu annealed at 1000 °C for 6 h
compared to NaGdF4:Eu nanophosphors synthesized using co-precipitate and
hydrothermal methods. Taken with permission of ref 1. .................................................. 93
Figure 3. 13: TEM images of NaGdF4:Eu@SiO2 nanophosphors annealed at (A) 400 °C,
(B) 600 °C (C) 1000 °C. Taken with permission of ref 1. ................................................ 94
Figure 3. 14: (A) XEOL of NaGdF4:Eu@SiO2 annealed at 400 °C, 600 °C and 1000 °C
for 6 h. (B) Powder XRD pattern of annealed NaGdF4:Eu@SiO2 at 600 °C and 1000 °C
compared to PDF cards 00-056-0184 and 00-027-0699 biotin functionalized
NaGdF4:Eu@SiO2. Taken with permission of ref 1. ........................................................ 94
Figure 3. 15: X-ray excited optical luminescence (XEOL) spectra of bare synthesized,
silica coated, and silica coated annealed Eu-doped NaGdF4 NPs. Taken with permission
of ref 1. .............................................................................................................................. 95
Figure 3. 16: XEOL spectra of NaGdF4:Eu@SiO2 unannealed and annealed at 150, 400,
and 1000 °C for 12 hours. Taken with permission of ref 1. ............................................. 96
Figure 3. 17: Schematic illustration of (A) silica coated nanophosphors functionalized
with biotin (i) silica-coated NaGdF4:Eu nanophosphors, (ii) amine-functionalized
nanophosphors, (iii) biotin-functionalized nanophosphors. Biotin is connected to aminefunctionalized nanophosphors via sulfo-NHS groups, (B) biotin functionalized
nanophosphors attach to streptavidin coated silica microbubbles. (i) streptavidin-coated
silica microbubbles, (ii) biotin-functionalized nanophosphors attached to streptavidincoated silica microbubbles. (C) SEM image showing biotin-functionalized
nanophosphors attached to streptavidin-coated microbubbles. Taken with permission of
ref 1. .................................................................................................................................. 97
Figure 3. 18: Schematic illustration of measuring XEOL of NaGdF4:Eu filled in
capillaries (A1) without tissue (B1) sandwiched with two 5 mm porcine tissues. XEOL of
NaGdF4:Eu filled in capillaries (A2) without tissue (B2) sandwiched with two 5 mm
porcine tissues. Exposure time was 10 s without tissue and 60 s through tissue. Taken
with permission of ref 1. ................................................................................................... 99
Figure 3. 19: XELCI images of NaGdF4:Eu dispersion in capillaries (A) XELCI images
without tissue (i) image of 620 nm intensity (counts) vs. position. (ii) Image of 700 nm
intensity (counts) vs. position (iii) XELCI ratio image (intensity ratio of 620 nm and 700
nm). (B) XELCI images of the same capillaries sandwiched between two 5 mm porcine
tissue slices (i) 620 nm image (ii) 700 nm image (iii) XELCI ratio image. (iv)
Superimposed 620 nm image and X-ray transmittance images. Current was 200 μA
without tissue and 600 μA through tissue. 1 mm scale bar is same for all images. Taken
with permission of ref 1. ................................................................................................. 100

xvi

Figure 3. 20: Full-scale XEOL of NaGdF4: Eu in capillaries A) without tissue B)
sandwiched between 5 mm slices of porcine tissue. Taken with permission of ref 1. ... 101
Figure 3. 21: Magnetic resonance images (MRI) of NaGdF4:Eu and NaGdF4:Tb
nanoparticle suspensions in water. (A) T1 weighted and (B) T2 weighted images with
various nanoparticle concentrations. 0 mM = DI water. 1 cm scale bar is for both T1 and
T2 weighted images. (C) Longitudinal relaxation rate vs. concentration for nanoparticle
suspensions. (D) Transverse relaxation rate vs. concentration. Dashed lines are linear fits
to data. Taken with permission of ref 1. ......................................................................... 102
Figure 4. 1: Design of new lateral flow assay to test anti-spike IgG and IgA in human
saliva. .............................................................................................................................. 122
Figure 4. 2: Schematic illustration of (i) preparing RBD conjugated AuNPs and antihuman IgG conjugated Ulfa tag, (ii) combining RBD conjugated AuNPs, human IgG
conjugated Ulfa tag, and biotin-conjugated AuNPs, (iii) dipping the LFA test strip.
Images of LFA test strip. Images of LFA test strips after running (B) human anti-spike
IgG and (C) human anti-spike IgA. ................................................................................ 123
Figure 4. 3: (A) Schematic illustration of functionalizing route of RBD functionalized
AuNPs. (B) UV-Vis spectra showing λmax of bare AuNPs, Au@PEG, Au@PEG:RBD
and RBD protein in different buffer solutions. ............................................................... 125
Figure 4. 4: (A) Schematic illustration of RBD functionalized AuNPs binding to antispike IgG GOS:Eu microparticles. (B) Image showing control and the sample under UV
light irradiation. (C) TEM image of RBD functionalized AuNPs bound to anti-spike IgG
GOS:Eu microparticles. (D) X-ray excited optical luminescence of control and the
sample. ............................................................................................................................ 127
Figure 5. 1: (A) Sterilizing a spatula by dipping in 70%ETOH and flaming. (B) Taking a
1 cm x 1 cm agar chunk from a NGM agar plate containing C. elegans. (C) transferring
agar chunk into a fresh plate with an E. coli lawn. ......................................................... 140
Figure 5. 2: (A) A Photograph (B)schematic diagram of the experimental setup. The
schematic diagram's right shows an X-ray spot visualized on a Grafchromic film and a
worm targeted to X-ray exposure. .................................................................................. 143
Figure 5. 3: The behavior of Pmyo-3::lite-1 (A1) before X-ray on and (A2) after X-ray
on. The behavior of N2 (B1) before X-ray on and (B2) after X-ray on. The purple region
corresponds to the worm movement during 10s before or 10s after the X-ray on. Worm
shape and location are equivalent to the initial frame before or after the X-ray on. ...... 144
Figure 5. 4: MATLAB generated an image of Pmyo-3::lite-1 1s before and after ejecting
an egg. The blue circle shows the ejected egg. ............................................................... 145
Figure 5. 5: A graph of the number of eggs ejected after X-ray on vs. worm number
(Pmyo-3::lite-1). ............................................................................................................. 146
Figure 6. 1: SEM images of Ag NPs (A) unrolled and (B) rolled AgNPs. (C) SEM image
of fused NPs during the deformation process ................................................................. 152

xvii

Figure 6. 2: Methyl orange color reduction by NaBH4 using Ag NPs as a catalysts. (AiCi) Negative controls. (Aii) 10 minutes and (Aiii) 15 minutes after adding 200 µL of 1%
(v/v) AgNPs. Five minutes ofter adding (Bii) 200 µL and (Biii) 400 µL of 1% (v/v)
AgNPs. Five minutes after adding 100 µL of (Cii) 100 nm and (Biii) 50 nm of 1% (v/v)
AgNPs. ............................................................................................................................ 153
Figure 6. 3: (A) Low resolution and (B) High-resolution XEOL spectra from NaGdF4:Eu,
Gd2O2S:Eu and a mixture of both with spectrally distinct peaks. .................................. 155
Figure 6. 4: Calibration curve of (Ai) 616/626 nm intensity ratio and (Aii) 695/703
intensity ratio vs weight of NaGdF4:Eu (mg) of simulated data. Calibration curve of (Bi)
616/626 nm intensity ratio and (Bii) 695/703 intensity ratio vs weight of NaGdF4:Eu
(mg) of experimented data. ............................................................................................. 157
Figure 6. 5: Calibration curve of (Ai) 626/616 intensity ratio and (Aii) 703/695 intensity
ratio vs. weight of NaGdF4:Eu (mg) of simulated data. Calibration curve of (Ai) 626/616
intensity ratio and (Aii) 703/695 intensity ratio vs. weight of GOS:Eu (mg) of
experimented data. .......................................................................................................... 158
Figure 6. 6: (A) Schematic illustration of protein depletion assay. (B) UV-Vis spectra
show λmax of AuNPs after bioconjugation, RBD before, and after bioconjugation. ....... 160

xviii

CHAPTER ONE
INTRODUCTION
Materials with at least one dimension in the range of 1-100 nm are known as
nanomaterials. Compared to biological structures, the nanoparticle size range lies
between the size of DNA and most viruses, and they can be observed under electron
microscopes and X-ray crystallography (Figure 1.1- figures were taken from various
sources1,2). Nanoparticles have unique properties compared to their bulk materials, such
as optical properties and a high surface-to-volume ratio necessary for biomedical
(bioimaging, sensing) and other industries (catalysis). Nanoparticles such as plasmonic,
silicon, quantum dots, and lanthanide-doped nanoparticles have unique optical properties
(e.g., generating visible light). The other important feature of nanoparticles is they have a
large surface area and internal volume that can be used as a platform for carrying and
delivering several different “payloads” to control their optical, X-ray, magnetic, drug
release, and other properties. These platforms can be functionalized with biomolecules
such as proteins (antibodies, antigens, enzymes, etc.)3,4 and nucleotides (single-strand
DNA, RNA)5 to target biomarkers in vitro and in vivo6. Due to the nanoparticles' optical
properties and surface area are widely used in the biomedical field for bioimaging,
sensing, and therapeutic applications7.
The size of a nanoparticle plays a vital role in these applications due to sizedependent optical properties and penetration through vascular systems, and retention time
in the blood circulation system. Here we are interested in studying the optical properties
of plasmonic and X-ray luminescence nanoparticles around 100 nm in size for
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bioimaging and sensing applications. Nanoparticles in this range (~100 nm) have
prolonged circulation time and tend to accumulate in perivascular spaces of permeable
tissues such as liver and spleen, tumor, site of inflammation, and angiogenesis, allowing
bicomponent imaging. Also, the nanoparticles smaller than 5-10 nm and ~70 nm are
removed by fast renal filtration and fenestrae of hepatic sinusoids filtration respectively,8–
10

and larger than ~200 nm by endocytosis or phagocytosis (mononuclear phagocyte

system (MPS))8,9,11, limiting bioimaging. Other than the size of the nanoparticles, shape,
hydrophobicity/hydrophilicity, surface charge, and functional groups attached to
nanoparticles are important in blood circulation and penetration through tissue12.

Figure 1. 1: Size comparison of nanoparticles of interest to some biological components. Modified
from ref. 1.

In this dissertation, we are interested in developing plasmonic and X-ray
luminescence nanoparticles for bioimaging and sensing applications. Under this theme,
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three different research projects were carried out to understand, alter and enhance the
optical properties of these nanoparticles. Also, they were functionalized and used in
bioimaging and sensing applications.
The size-dependent optical properties are crucial in biomedical applications, and
it is discussed in this chapter for plasmonic and X-ray luminescence nanoparticles (1.11.2).

1.1. Plasmonic Nanoparticles for Imaging and Sensing Applications
Plasmonic nanoparticles such as gold (Au) and silver (Ag) have a characteristic
optical property called localized surface plasmon resonance (LSPR). As described in the
literature, LSPR is when the incident light impinges on a nanoparticle, it generates
enhanced electromagnetic fields that are localized at the surface of the nanoparticle
(Figure 1.1)13,14. When the incident light strikes a nanostructure, it collectively oscillates
the conduction band electrons, resulting in absorption and/or a scattering of the
wavelength of the incident light by the nanostructure.
For particles much smaller than the wavelength of light, the nanoparticle’s
electromagnetic behavior can be classically approximated by a dipole response. For
ellipsoidal particles, the electric polarization generated in the particle in response to an
alternating electromagnetic wave (light) depends on the particle shape, electric
permeability, and incident light wavelength and polarization. The extinction can be
calculated from the particle’s polarization according to the following equation, with the
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first term corresponding to absorption and the second term to scattering: (Equation
1.1)15,16.
𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸 =

3/2
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…….…1.1

Where N= electron density of the nanoparticle, a= radius of the nanoparticle, εm=

dielectric constant of the surrounding medium, εi= imaginary portion of the metallic
nanoparticle's dielectric function, εr= real portion of the metallic nanoparticle's dielectric
function, χ= shape- factor (2 for nanospheres) related to the depolarization factor L as 1/L
- 1, and λ= wavelength of incident light. Since the absorption term has an a3 dependence,
while the scattering term has an a6 dependence, absorption dominates for small particles,
while scattering dominates for large particles, the transition is typically around ~30 nm.17
The depolarization factor can explain shape dependence LSPR (Figure 1.1C)15, which has
three components, L1, L2, L3, along each axis (Equations 1.2-1.4)15,16. The corresponding
LSPR frequencies are different in different directions. For a nanorod with a>b=c,
𝐿𝐿1 =

1−𝑒𝑒 2
𝑒𝑒 2

1

1+𝑒𝑒

�2𝑒𝑒 ln �1−𝑒𝑒� 1�……………………………………………………….1.2

𝐿𝐿2 = 𝐿𝐿3 =

1−𝐿𝐿1

1

2

………………………………………………………………….1.3

𝑒𝑒 = �1 − 𝑅𝑅2………………...…………….…………………………………….1.4

R2= aspect ratio (a/b)

From equation 1.1, a noble metal nanoparticle’s absorption, scattering, and
extinction spectra each have a maximum λmax which occurs when the close to when 𝜀𝜀𝑟𝑟 +

𝜒𝜒𝜒𝜒𝑚𝑚 = 0 and the denominator, (𝜀𝜀𝑟𝑟 + 𝜒𝜒𝜒𝜒𝑚𝑚 )2 + 𝜀𝜀𝑖𝑖2 , is minimized. Figure 1.1B shows the
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dielectric function of silver. The imaginary part is relatively frequency independent
through the visible spectral range, while the real part is rapidly increased to a large
negative value with wavelength. Specifically, the real part of the metal dielectric function
can be approximately fit to the Drude model, εr = 1-λ2/λp2 where λp is the plasmon
resonance wavelength of the metal. Plugging this into the condition above for resonance,
we have 𝜀𝜀𝑟𝑟 + 𝜒𝜒𝜒𝜒𝑚𝑚 = 0 → 1 −

λ2𝑚𝑚𝑚𝑚𝑚𝑚
λ2𝑝𝑝

+ 𝜒𝜒𝜒𝜒𝑚𝑚 = 0. When 𝜒𝜒𝜒𝜒𝑚𝑚 ≫ 1, we find λ𝑚𝑚𝑚𝑚𝑚𝑚 ≈

λ𝑝𝑝 √(𝜒𝜒𝜒𝜒𝑚𝑚 ). For media with low absorbance, the square root of the dielectric constant is

essentially equal to the refractive index; thus, we have λ𝑚𝑚𝑚𝑚𝑚𝑚 ≈ λ𝑝𝑝 𝑛𝑛√𝜒𝜒. The absorption

and scattering of the nanoparticle thus depend on the material composition (especially
λp), nanoparticle size (which at very small sizes can affect the metal’s dielectric
properties and at sizes above around λ/2π need a more complex theory than the dipole

approximate, to include phase retardation affects and multipole resonance), nanoparticle
shape (especially the shape factor), refractive indices of surface-bonded species of
nanoparticles, the refractive index of surrounded media, etc18

ε1= real
ε2= imaginary

Figure 1. 2: (A) Schematic diagram illustrating a localized surface plasmon resonance. (B) real and
imaginary parts of the dielectric function of silver as a function of wavelength. Taken with
permission of ref. 6 (C) Calculated extinction spectra of gold nanorods with varying aspect ratios.
Taken with permission of ref. 3
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The size, shape, and medium refractive index tunability of LSPR and associated
optical absorption and scattering is useful for developing optoelectronic devices,
biosensors, identifying molecules, in vivo imaging, etc14,19,20. Plasmonic nanoparticle
arrays (1,2 and 3D) are widely used in manipulating light and matter interactions at the
nanoscale and in diverse applications such as developing biosensors due to photonic and
plasmonic attributes. These plasmonic nanoparticle arrays show enhanced
electromagnetic fields, high-quality optical responses (enhanced and well-resolved
extinction peaks, red or blue-shift in plasmon resonance, and Surface Enhanced Raman
Spectroscopy (SERS)21–23). Different regions of nanoparticle arrays are also used in
multiplex diagnostic systems such as lab-on-a-chip devices to detect multiple biomarkers
simultaneously. Therefore, investigating methods to prepare nanoparticle arrays are
crucial.
There are several methods to prepare nanoparticle arrays, such as e-beam
lithography, chemical vapor deposition, pulsed laser ablation, etc24. However, these
methods are complex, time-consuming, expensive chemical methods that require trained
personnel to perform. In 1996 Stephen Chuo introduced the nanoimprint lithographic
technique as a low-cost, high throughput technique alternative to photolithography and ebeam lithography25. Most nanoimprint lithographic approaches use contact printing26,
chemical etching27, and reel to reel processes28.
Similar to preparing nanoparticle arrays transferring these prepared nanoparticles
onto desired substrates (thin-films or flexible polymers) is also important (hybrid
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optics29). Most common approaches require high temperature, vacuum conditions,
sacrificial layers, and surfactant coated nanoparticles30,31.
Developing inexpensive, simple, and robust techniques to prepare nanoparticle
arrays with controlled shape and transferring them to desired substrates are still
challenging and crucial matters. Chapter two describes the development of simple and
robust mechanical methods to make nanoparticle arrays and transfer them onto a thin
polymer film.

1.2. X-ray Luminescence Nanoparticles for Imaging and Sensing Applications
Like plasmonic nanoparticles, X-ray luminescence nanoparticles (scintillators,
nanophosphors) are nanomaterials that have an interesting optical property called X-ray
excited optical luminescence (XEOL). X-ray photons can maintain focus through thick
tissue, unlike optical photons (which have short mean free-scattering paths in tissue), and
thus one can use a narrow X-ray beam only to excite XEOL from nanoscintillators in a
specific region. By scanning the X-ray through the tissue and using the known X-ray
beam location as a permissible region for optical emission, one can reconstruct high
spatial resolution, low background images through thick tissue. Nanophosphors are
nanostructured, and insulating materials efficiently emit visible light under X-ray
(particle and photon) excitation. During the last few decades, they have been widely
studied for applications like sensors32,33 and medical imaging34,35, etc. However,
synthesizing nanosized, monodisperse particles with bright luminescence is still
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challenging and their properties depend on precursor formation, particle growth, the
formation of lattice defects, crystal domain size, and surface modifications36,37.
Many different synthesis routes (organic and inorganic) have been developed to
synthesize nanophosphors. Co-precipitation, thermal decomposition, and solvothermal
synthesis are some examples. Some synthesis routes, such as hydrothermal synthesis and
sol-gel process, are performed in aqueous media (inorganic synthesis)38.
The co-precipitate method is one of the most accessible and convenient
approaches to synthesizing X-ray luminescence nanoparticles because of its mild reaction
conditions, low cost, simple protocols, and short reaction time. The co-precipitation
process generally shows the following characteristics according to LaMer's model39. The
products are insoluble species formed under conditions of supersaturation, 1. A large
number of seed particles will be created during nucleation, 2. Formation and growth of
seed particles decrease reagent concentration below minimum nucleation concentration
and existing seeds growth, limited by reagent diffusion or reaction until eventually,
reagent concentration reaches equilibrium with particles. 3. The secondary processors
such as Ostwald ripening and aggregation affect the particle size, morphology, and
properties. The supersaturation conditions necessary to induce precipitation are usually a
chemical reaction40 (e.g., Gd (NO3)3 + Eu (NO3)3 + urea  Gd2O(CO3)2.H2O:Eu)41.
However, nanoparticles synthesized by this method have law luminescence intensity.
Therefore, annealing treatments are required to enhance the luminescence resulting in a
phase transition from hexagonal (α) to cubic (β).
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In a broader sense, hydrothermal synthesis can be performed from room to high
temperatures and low pressure to high-pressure environments42. However, the size and
morphology of synthesized nanocrystals depend on the solvent's temperature, pressure
and dielectric constant, etc. Hydrothermal syntheses are typically performed below 300
°C in an autoclave. As the temperature develops, solvent/water dramatically changes to
supercritical conditions. Under supercritical conditions, the dielectric constant remains
below 10, and the reaction medium becomes favorable for crystal growing, based on
electrostatic theory. Therefore, supercritical solvents give a favorable reaction
environment for particle formation by enhancing the reaction rate and creating a
significant supersaturation based on the nucleation theory due to lowering the solubility43.
The hydrothermal method usually gives a relatively high yield of desired products with
controlled size, shape, and crystallinity.
One of our key goals was to synthesize the brightest luminescent particles for a
given X-ray dose. The X-ray scintillators can serve as optical contrast agents with low
background. Their position can be detected at high spatial resolution through tissue using
a narrow X-ray beam: the X-ray beam provides a small permissible region for the light
generation to excite only particles within the beam. The maximum quantum yield of Xray scintillators (photons emitted per MeV) is determined by the band gap of the host
matrix (Equation 1.5)44.
𝑌𝑌 =

106

2.5𝐸𝐸𝑔𝑔𝑔𝑔𝑔𝑔

……………………………………………………………………1.5

Where Y= quantum yield (photons per MeV of incident X-ray photon energy), Egap=
band gap (eV). The photons emitted have less energy than Eg, so the conversion
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efficiency between absorbed X-ray energy and emitted optical energy is less than 1/2.5
(<40% energy efficiency); for example, it is around 10-15% in bulk Gd2O2S:Eu or
Gd2O2S:Tb scintillators.
The X-ray luminescence yield of lanthanide-doped nanoparticles also depends on
the nanoparticle's size, host material/ lattice structure, crystallinity, and amount of
activator and impurity dopants, especially as these relate to energetic photoelectron and
exciton diffusion lengths. High X-ray luminescence intensity can be achieved by
choosing the best host materials (e.g., host materials with sulfur and oxygen are better
than iodine and bromide, small band gap44), increasing crystallinity, and incorporating the
right amount of dopants. Luminescence intensity is a key factor in most bioimaging
applications (E.g., The quantum yield of bulk Gd2O2S:Eu is 60 000 photons per MeV.44)
because it contributes to the sensitivity of the biomarker detection.
For bioimaging and sensing applications, understanding light attenuation and
collection through tissue is important. Light attenuation through tissue is one of the
fundamental limitations in optical imaging, and it reduces the number of photons emitted
by the volume of tissue, leading to low sensitivity. The number of visible photons
detected per voxel from a sample is calculated by equation 1.6.44
𝑛𝑛𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣 = 𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷…………………………………………………………….1.6

Where nvisible= number of visible photons detected per voxel from a sample (signal), D=
X-ray dose applied to the tissue (J/kg), Γ= X-ray to luminescence conversion efficiency
(photons/J), f= X-ray absorption by particles/ absorption by tissue, c= nanoparticle
concentration (volume fraction), V= voxel volume (kg), L= light collection efficiency
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(includes transmission through tissue, capture through the light guide, and photodetector
quantum efficiency).
Below, we work through a representative example, explaining trade-offs between
dose, particle concentration, spatial resolution, and tissue depth for a given setup and
nanophosphor quantum yield.
For example, the number of visible photons detected per voxel from a given
sample can be calculated with the following information.
D, X-ray dose applied to the tissue= 0.01 Gray (J/kg)
𝛤𝛤, X-ray to luminescence energy efficiency of nanoparticles.

Assuming a quantum yield= 20 000 ph/MeV (if we consider 30% of bulk Gd2O2S:Eu), 1
eV= 1.6*10-19 J
= 20000 ph/ 1.6*10-19 * 106 eV = 1.25*1017 ph/J
f, depends on the X-ray energy, but can be as high as ~500 for Gd2O2S (with scintillator
absorbing 500x more than tissue) = 500
c, Nanoparticle concentration (volume fraction) = Volume of nanoparticles/Volume of
tissue= Concentration of nanoparticles (g/mL)/ density of the nanoparticle (g/mL).
Assuming a concentration of 0.2 mg/mL, we have:
c = 0.2 x10-3 g/mL/ 7.43 g/mL= 2.69*10-5
V, Voxel volume for a 0.5 mm cube= 0.125 µL or 1.31*10-7 kg
L, Light collection efficiency= light transmittance to skin* internal reflection at skin*
fraction captured through the light guide* photodetector (PMT) quantum efficiency
The light transmittance to the skin is calculated using the following equation44.
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𝐼𝐼 = 𝐼𝐼0 𝑒𝑒 −𝜇𝜇𝜇𝜇 ………………………………………………………………………………1.7
Where I= light transmitted to the skin, I0= light generated by the scintillator, µ=

effective light attenuation coefficient of tissue, this depends strongly on wavelength and
type of tissue, x= travel distance through tissue. Assuming, µ=0.42 mm-1 (e.g., reported
value for arm tissue at 620 nm,45 and x= 0.6 cm, we get 8% transmittance through the
tissue46.
To calculate the fraction captured through the light guide, the maximum fiber
acceptance angle of 90 degrees for acrylic in air light guide47. Our system is fairly
efficient with an acrylic light guide, which may collect light at 50 ° with 1-inch collection
optics46. It was calculated using the following equation. (1-COS(RADIANS (50)))/2 =
17.86%. Note, some light aimed into tissue; naively estimate ½.
The PMT quantum efficiency of 5% at 600 nm was taken from the datasheet of
photodetector module P25PC-16, SENS TECH, UK48.
Thus, the overall collection efficiency = 8%* 0.5 * 17.86%* 5%= 3.6*10-4
Putting this together, we get:
n visible, Number of visible photons detected per voxel from a sample=
J
∗ 1.25∗1017 ph/J∗500∗2.69∗10−5 ∗1.31∗10−7
kg

0.01

1

kg∗3.6∗10−4

= 792 𝑝𝑝ℎ

Thus, if 0.2 mg/mL of Gd2O2S:Eu nanoparticles are inserted 6 mm below the surface
(skin) and irradiated with a 0.01 J/kg X-ray dose, with a light collection efficiency of
3.6*10-4, 792 photos are generated per (500 µm3) voxel.
The next question is, 792 photons are enough to get a good signal. For that, we
have to consider the background signal/ noise. Noise can be found experimentally or
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must be higher than the fundamental limit from shot noise, which can be calculated using
the following equation (1.8)49.
𝑛𝑛𝑒𝑒𝑒𝑒𝑒𝑒 = �𝑛𝑛𝐷𝐷2 + 𝑛𝑛𝑠𝑠2 ………………………………………………………1.8

Where neff= total effective noise, nD= shot noise from dark counts (generated from
current that flows even when no photons are incident, depending on temperature), ns=
shot noise from detected photoelectrons.
In this scenario, noise mainly comes as shot noise from dark counts and detected
XEOL signal. According to the PMT datasheet, dark counts (counts of photoelectrons)
are 1000 s-1 at 20 °C. Thus for a 1 s exposure,
𝑛𝑛𝑒𝑒𝑒𝑒𝑒𝑒 = √1000 + 792 = 42.

Considering the signal-to-noise ratio, it is 792/42= 18.9, a fair number. This is a

representative calculation showing both the feasibility under possible scenarios as well as
tradeoffs. In real-world performance, we may use X-ray scintillators with relatively low
luminescence yield (e.g., <5%), may want to detect lower concentrations of particles, and
need to achieve a small voxel size (e.g., 50 µm length), or image through thicker tissue
with more light attenuation. Therefore, the number of photons detected per voxel (signal
or signal-to-noise ratio) can be relatively small. However, several factors can be changed
to obtain a high signal-to-noise ratio, such as 1) increasing the X-ray dose. For context,
while one wants to minimize the dose, 0.01 J/kg could be improved as typical full-body
equivalent doses, doses for rodents in µ-CT are 1-100 mJ/kg, and repeated sublethal
doses are tolerated up to 3 J/kg, with lower doses tolerated for smaller exposed regions50;
2) increasing voxel volume (decreasing spatial resolution); 3) increasing nanoparticle

13

concentration; 4) improving light collection efficiency (this can be dramatically improved
with better light collection optics and higher quantum efficiency photodetectors); or 5)
decreasing dark counts by running faster acquisitions or decreasing PMT temperature.
Given these variables, a sufficiently intense signal should be detectable through tissue
with reasonable particle concentrations, X-ray doses, tissue thickness, and spatial
resolution. However, there are tradeoffs with each of these variables, and using bright
luminescence particles is key for allowing higher spatial resolution, lower dose, or lower
particle concentration measurements.
As explained at the beginning of this section 1.2, we are interested in synthesizing
bright X-ray luminescence nanoparticles and enhancing their luminescence intensity.
However, our challenge is to obtain bright X-ray luminescence intensity with nanosized
particles. Apart from choosing the right lattice structure, dopant amount, and reducing
defects, nanoparticle annealing, surface passivation, and coating with inorganic and
organic insulating layers51 are some techniques used to enhance luminescence in X-ray
luminescence and upconversion nanoparticles. Chapter three describes the synthesis of
bright X-ray luminescence nanoparticles (NaGdF4:Eu and NaGdF4:Tb), annealing them
to improve the X-ray luminescence intensity, and using them in spectroscopy and highresolution imaging through tissue.
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1.3. Applications of Plasmonic and X-ray Luminescence particles: Developing
immunosensors
As mentioned in the above sections, plasmonic and X-ray luminescence
nanoparticles' optical properties and a surface area to functionalize them with
biomolecules to develop biosensors.
To perform most clinical assays requires trained personnel and expensive,
complex instruments. Therefore, most clinical assays are not readily available in
developing countries and investigating and developing innovative analytical methods to
accurately screen and diagnose diseases are important. In recent years, plasmonic and Xray luminescence NPs have been widely used in developing immunoassays.
immunosensors because of their interesting optical properties and increased surface area.
Plasmonic nanoparticles have interesting optical properties such as scattering and
absorption of visible range wavelength due to surface plasmon resonance (SPR) to
develop naked-eye immunoassays 52–54, surface-enhanced Raman spectroscopy (SERS) to
develop SERS-based immunoassays55–57. These properties are useful in the detection and
quantification of analytes. Further, they have interesting enzyme mimicking properties
important in increasing sensitivity54,58. Likewise, X-ray luminescence particles are used
in developing X-ray luminescence-based immunoassays59,60. Due to the weak scattering
and absorption of most biological tissue by X-ray excitation, a low-dose X-ray source can
be used to produce intense, scintillating luminescence. Also, the other advantages are
narrow and distinct spectral emission peaks, large optical penetration depth, negligible
autofluorescence background, photochemical stability, and low toxicity41.
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Therefore, taking advantage of plasmonic and X-ray luminescence particles, it is
important to develop immunoassays/ immunosensors which are timely required. Chapter
four describes the design and development of an LFA using gold nanoparticles to detect
SARS-CoV-2 antibodies in human saliva and the proof of concept of an implantable
immunoassay using gold nanoparticles and X-ray luminescence nanoparticles.

1.4. Radiation-Induced Behavior of Caenorhabditis elegans
This section discusses a different concept to the main theme of optical properties
of plasmonic and X-ray luminescence nanoparticles and functionalizing them for
bioimaging and sensing applications. Here, we discuss the X-ray avoidance behavior of
C. elegans. However, it can be related to the main theme regarding sensing X-ray
radiation.
One of the goals of neuroscience is to understand how the actions of neurons and
nerve systems cause behavior. To fulfill this goal, C. elegans can be used as a model with
a number of unique advantages such as having a highly conserved and compact nervous
system containing 302 neurons, simple anatomy, neurochemistry and genetics similar to
mammals, optical transparency and small size, etc61. C. elegans is a tiny, free-living,
transparent nematode (roundworm) that lives in a soil environment. The length of an
adult worm is about 1-1.5mm (Figure 1.1). They are easy to grow on a petri dish seeded
with Escherichia coli as a food source. Also, they are fast-growing animals with a short
life cycle (3 days). It is difficult to see them with the naked eye because of their small
size and transparency. However, dissecting microscopes are used to visualize their
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movements, eating habits, developments, and laying eggs; confocal microscopes can be
used to see cell development and function at a single-cell resolution. Further, proteins and
other cell components can be visualized by fluorescence staining. C. elegans is a
powerful model for eukaryotic genetic studies. They are the only animal for which the
complete atlas of synaptic connectivity has been mapped and the first multicellular
organism with a complete genome sequence62. C. elegans are widely used in studying
sensory cues such as mechanical forces, temperature, chemicals, and radiation (especially
UV), showing negative phototaxic effects63. Chapter five includes the study of X-ray
stimulated egg ejection of C. elegans. This is the first research carried out to study X egg
ejection of C. elegans using X-ray as a stimulant.
Chapter six includes the projects' summary and future work of chapters two,
three, and four.
In summary, this dissertation focuses on developing plasmonic and X-ray
luminescence nanoparticles for bioimaging and sensing applications. The main problems
addressed in the dissertation are 1) developing a simple mechanical method to prepare
plasmonic nanoparticle arrays and transfer nanoparticle arrays onto thin films, 2)
enhancing the intensity of X-ray nanoparticles and imaging through tissue, 3) developing
immunoassays using plasmonic and X-ray luminescence particles. Apart from the main
topics, this also includes a study to discover and understand the X-ray stimulated
behavior of C. elegans.
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CHAPTER TWO
IMPRESSIVELY PRINTING PATTERNS OF GOLD AND SILVER
NANOPARTICLES
Much of the material in this chapter was published as a journal article: Ameer, F. S.;
Ranasinghe, M.; Varahagiri, S.; Benza, D. W.; Hu, L.; Willett, D. R.; Wen, Y.;
Bhattacharya, S.; Chumanov, G.; Rao, A. M.; Anker, J. N. Impressively Printing Patterns
of Gold and Silver Nanoparticles. Nano Select 2021, 2 (12), 2407–2418.
https://doi.org/10.1002/nano.202000278.

2.1. Abstract
The optical and chemical properties of gold and silver nanoparticles make them
useful for many applications, including surface-enhanced spectroscopy-based biosensors,
photostable colorants, enhanced photovoltaic, and nanoscale optical elements. We
report a simple technique to generate patterns of gold and silver nanoparticles with
controlled shape and shape-dependent optical properties using metal stamps and glucose
deposit to impress them onto a glass substrate. The pressure flattens the nanoparticles,
converting initially spherical nanoparticles into discs with reduced height and increased
diameter. This deformation causes their localized surface plasmon resonance wavelength
to red-shift. Nanoparticles were characterized by electron microscopy, atomic force
microscopy, and darkfield optical scattering spectroscopy. The deformed nanoparticle
patterns had a lateral resolution limited by the nanoparticle diameter (single particles are
partly flattened, only where they contact the stamp). The method also transfers the
stamp's topography, with smooth stamps generating flattened nanoparticles with uniform
height, and small changes in stamp height are evident in the nanoparticle height
and scattering wavelength. Patterning with glucose deposits generated circle patterns, and
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nanoparticle height decreased when they go away from the glucose deposit. The height
changes are evident in darkfield and atomic force microscopy images. Also, the method
allows facile removal of undeformed nanoparticles using scotch tape, and patterns of
deformed nanoparticles can be transferred to a flexible polymer film. The
patterning process is simple and inexpensive. It can be performed by hand for
demonstrations or artistic applications, with a controlled force for plasmonics research,
and potentially automated on reel-to-reel presses for large-scale production.

2.2. Introduction
Light irradiating plasmonic gold and silver nanoparticles (AuNPs and AgNPs) are
strongly absorbed and scattered at wavelengths that depend upon the nanoparticle's size,
shape, and the refractive index of its surroundings. These optical properties arise from
optically-driven resonant oscillations of conduction electrons in the nanoparticle, termed
as the localized surface plasmon resonance (LSPR). The shape and refractive index
dependent properties are explained briefly in Chapter 1, section 1.1 of this Dissertation.
Plasmonic nanoparticles are used in a variety of applications, including as labels in
immunoassays,2–3 agents for photothermal therapy,4,5 lithographic fabrication,6–
8

photostable colorants for printing,9,10 staining glass windows,11,12 coloring

coins,11,12 making anti-counterfeit labels,13,14 components in nano-optical switches and
waveguides,15,16 meta-materials with negative refractive indices, catalysis,17,18 and
biosensors and labels based on surface-enhanced spectroscopies.19–24 While considerable
effort has been directed towards the synthesis of noble metal nanoparticles with
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controlled size and shape, printing patterns of metal nanoparticles with different shapes
on a solid substrate remains challenging.
To form plasmonic nanoparticle patterns, top-down lithographic approaches are
commonly used. For example, ion beam etching can be used to etch away a film into
arrays of nanoparticles with a precisely controlled shape and pattern.25 Once a master
pattern is formed using slow lithographic approaches, it can then be used to make submasters, which can be used as stamps in nanoimprint lithography via contact printing26 or
chemical etching.27 Such nanoimprint lithography can be made compatible with reel-toreel processes for rapid reproduction over large areas.28 However, generating the master
stamp is slow and expensive, and the remaining processes require multiple steps such as
heating the substrate to an appropriate temperature, performing photolithography
exposure/baking/development steps, and/or vapor depositing gold or silver. Several other
techniques have been developed to pattern nanoparticles using pulsed laser
writing,29 nanosphere lithography (also called colloidal lithograph)30, and others.
However, these are still relatively slow and require processes such as vapor deposition,
which are rarely available outside of academic or industrial laboratories. Although these
techniques allow a careful control over nanoparticle height and aspect ratio through the
vapor deposition thickness, they are ill-suited for studying the effects of nanoparticle
shape while conserving volume or for applications in low-resource lab settings.
In our previous study, we described a simple technique to alter the shape of
AgNPs by rolling a glass tube over them with a controlled force to compress them
mechanically. The resulting shape change induces a red-shift in the LSPR scattering
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spectrum and exposes new surface areas.31 Herein, we report an expansion of our
previous work that shows the versatility of the deformation technique by using a stamp to
create complex and high-fidelity patterns. We also show that gold nanoparticles and
silver nanoparticles can be deformed using a rolling pin and/or stamp. This is important
for long-term applications because gold, unlike silver, does not oxidize. Additionally, we
show that the approach is simple enough to be performed by hand for minting, printing,
crafting applications, and educational activities such as the scientific outreach programs.
To provide more uniformity, mechanical systems with fixed force are used. Finally, we
show how to isolate the pattern on a glass slide and transfer the nanoparticles to flexible
substrates.

2.3. Methods
2.3.1. Methods and Instrumentation
All chemical reagents were obtained from Sigma Aldrich and used as received.
All aqueous solutions were prepared using deionized (DI) water (18.2 MΩ cm). Poly(4vinylpyridine) (PVP) (Mw = 60,000 Da) was prepared by dissolving a weighed quantity
of PVP into ethanol. Indium−tin oxide (ITO) coated glass (100 Ω cm-1) was purchased
from Delta Technologies, Limited. Samples were characterized using an enhanced
darkfield transmission optical microscope (Olympus BX41) equipped with a
hyperspectral imaging spectrophotometer (CytoViva Hyperspectral Imaging System
(HSI), Auburn, AL). Scanning electron microscopy (SEM) images were collected using a
Hitachi SEM-4800 field emission (Hitachi, Japan) electron microscope operating at an
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accelerating voltage of 15 kV and an average working distance of 8.4 mm. The average
nanoparticle size and particle size distribution were obtained using the ImageJ software.
Alteration of the height of particles was measured using a AIST-NT SmartSPM in noncontact mode with HQ:NSC14/AL BS cantilevers from Mikro-Masch with spring
constant of ca. 5.0 N m-1. Absorbance spectra were collected using a Shimadzu UV2501 PC spectrometer.
2.3.2. Poly(4-vinylpyridine) functionalization of glass substrate
Both ITO-coated and normal glass substrates were cleaned by sonication in
nanopure water for 15 minutes followed by drying inside a desiccators and plasma
treating for 10 minutes (Harrick Plasma Cleaner PDC – 32G). The cleaned glass
substrates were poly(4-vinylpyridine) (PVP) functionalized according to a previously
reported method.32 After modification with PVP, substrates were thoroughly rinsed in
reagent ethanol to remove all weakly bound polymer molecules leaving only a monolayer
directly adhered to the surface. Next, the PVP modified substrates were annealed at
120°C under ambient atmosphere for a few hours. For the experiments, both ITO-coated
and normal glass substrates were used. No significant impact on experimental results was
found with either because the NPs are deformed by the pressure exerted by the rolling
pin, which is independent of the nature of the substrate. However, ITO-coated glass
substrates were mostly used for scanning electron microscopy due to their electrical
conductivity.
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2.3.3. AuNPs and AgNPs Synthesis
AuNPs were prepared using the seeded growth method.33 Briefly, a solution of
2.2 mM sodium citrate in 150 mL of nanopure water was heated in a three-necked roundbottom flask attached to a condenser for 15 minutes under vigorous stirring. After boiling
had commenced, 1.0 mL of 25.0 mM HAuCl4 was injected. After appearance of a deep
red color, which indicates the formation of gold seeds, the mixture was boiled and stirred
for another 10 minutes. Next, the mixture was cooled to 90°C and 1.0 mL of 25.0 mM
HAuCl4 was injected. After another 30 minutes the reaction was completed. This process
was repeated twice. Then, the sample was diluted by extracting 55 mL of sample and
adding 53 mL of nanopure water and 2.0 mL of 60.0 mM sodium citrate. This solution
was then used as a seed solution and the process was repeated until the AuNPs had grown
to the desired size. The AuNPs with average diameter of ∼94 nm exhibited a maximum
extinction wavelength of 561 nm (Figure 2.1). We also used commercially purchased
AuNPs (EM.GC100, BBI Solutions, Anaheim, CA, USA) with average diameter of
∼72 nm that exhibited a maximum extinction wavelength of 520 nm (Figure 2.1).

AgNPs were synthesized using the hydrogen reduction method developed by

Evanoff and Chumanov33 Briefly, Ag2O was added to deionized water in a ratio of
1.0 gL-1 in a quartz reaction vessel. Next, 1.0 mM sodium silicate was added to promote
stabilization of the resulting AgNPs. The mixture was then shaken well before connecting
to the condenser and a hydrogen line. A heating mantle was placed under the vessel and
its contents heated and maintained at 70°C with constant stirring. Once the temperature
equilibrated, the vessel was flushed with H2 (99.9% purity) and pressurized to

34

10 psi. Hazard: over pressurizing or using a defective vessel may result in explosion and
cause severe injuries. Within 10−15 seconds of the initial pressurization, the contents of
the vessel turned faint yellow in color indicating the formation of metallic silver particles
10−15 nm in diameter. As the reaction progresses, aliquots can be taken through the
spout. Removing the aliquots from the reducing environment stops further growth of the
particles. Likewise, the reaction can be stopped at any time simply by releasing the gas
from the vessel. In this way, control of the particle diameter is purely a function of total
reaction time. AgNPs with 97 nm average diameter had a maximum extinction
wavelength of 502 nm (Figure 2.1).
2.3.4. Deposition of nanoparticles on PVP functionalized ITO glass slides
To prepare the samples for deformation, both colloidal AuNPs (72 nm and 94 nm)
and AgNPs (97 nm) were diluted with deionized water to an optical density (O.D.) of 1
(using wavelength at dipole maximum and 1 cm path length). This absorbance
corresponds to ∼2.3 × 1012 particles per mL for 97 nm AgNPs and ∼2.6 × 1010 particles

per mL for 72 nm AuNPs and ∼8.3 × 109 particles per mL for 94 nm AuNPs based upon
a previous study counting the number of particles absorbed onto a surface with wellknown dimensions and measuring decrease in optical density of nanoparticle
solution.32 PVP coated glass substrates were immersed in the diluted aqueous suspension
of colloidal either AuNPs or AgNPs overnight at room temperature to form a monolayer
of nanoparticles, then rinsed with reagent ethanol and dried overnight at room
temperature in a desiccator connected to a vacuum pump. This leads to a well-dispersed
configuration of colloidal either AuNPs or AgNPs on the substrate surface.
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2.3.5. Mechanical deformation of nanoparticles
Nanoparticles deposited on a glass slide can be manually deformed by rolling a
simple glass stirring rod over them while applying downward pressure (Figure 1). The
pressure was be more easily applied by replacing the stirring rod with a simple rolling pin
(a ¼ inch diameter glass tube with a metal rod through it). For controllable and uniform
deformation, the rolling pin was attached to an ESM 303 mechanical test stand equipped
with a 1000 N Mark-10 Force gauge with computer-applied force. Nanoparticles
immobilized on a PVP functionalized ITO glass substrate were then clamped to a linear
motorized stage LTS 300 (Thorlabs, City State). The rolling pin was placed on one end of
the slide to begin with. Mechanical force was applied by the ESM 303 and the stage was
moved forward and back to roll the glass tube over the length of the glass substrate 10
times (Figure 2.3). Our previous study showed a similar effect with a single
roll.34 However, single rolled deformed particles appear to have sharper edges compared
to the particles deformed by rolling the glass rolling pin 10 times.34 The applied force was
varied from 0 to 50 N with the number of times the slide was rolled and rolling speed
(500 µm s-1) were kept consistent for each experiment. The glass tubes were cleaned
several times using acetone and distilled water prior to use.
2.3.6. Dark field optical imaging
Optical scattering from patterned AuNPs and AgNPs was observed with a Nikon
TE2000 microscope in a transmission dark field imaging configuration using a 0.95-0.8
numerical aperture (NA) condenser and 100X oil immersion objective with a variable
aperture stopped down to just below 0.8 NA. Images were acquired on a Nikon D90
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camera; all parameters of the camera were controlled by Camera Control Pro2 software
(Nikon Instruments Inc., Melville, NY, USA).
2.3.7. Hyperspectral darkfield microscopy
Both undeformed and deformed AuNPs and AgNPs on PVP-functionalized glass
substrates were examined using enhanced dark field transmission optical microscope
(Olympus BX41) equipped with hyperspectral imaging spectrophotometer (CytoViva
Hyperspectral Imaging System (HSI), Auburn, AL). The concentric
imaging spectrophotometer was used to record optical scattering spectra from visible and
near infrared wavelengths (400-1000 nm) at a spectral resolution of 1.5 nm with 10 nm
scan size and pixel size 25 nm. The customized hyperspectral imager (mounted on a
microscope and controlled by Environment for Visualization software) was extracted
with complete spectral information from single or multiple pixels. All images were
acquired using a 40X oil with iris objective at identical gain (gain = 5) and exposure time
(0.1 ms).
2.3.8. Atomic force microscopy (AFM)
AFM images were collected for patterned AuNPs and AgNPs adsorbed on PVP
functionalized ITO glass substrates using an AIST-NT SmartSPM in non-contact mode
with HQ:NSC14/AL BS cantilevers from Mikro-Masch with spring constant of ca. 5.0 N
m-1. These cantilevers had an uncoated tip radius of about 8 nm with a 40° full tip cone
angle. AFM image processing was carried out with AIST-NT SPM Control Software.
Polynomial background subtraction and line fit corrections were employed in some AFM
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images. Histograms of undeformed and deformed NPs sizes were based on statistical
analysis of ∼100 nanoparticles to calculate average size with standard deviation.
2.4. Results and Discussion

2.4.1. Manual and force-controlled nanoparticle deformation
Gold and silver nanoparticles can be deformed by applying pressure to them. We
had previously demonstrated this with silver nanoparticles using a constant pressure
device. Here, we extended to more chemically inert gold nanoparticles and showed that
this could be done by hand. Spherical AuNPs of diameters 72 and 94 nm, and AgNPs of
diameter 97 nm were used for preparing patterned nanoparticle surfaces (Figure 2.1).
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Figure 2. 1: Characterization of (A) 97 nm diameter AgNPs, (B) 72 nm diameter AuNPs (B), and (C)
94 nm diameter AuNPs using UV-vis spectroscopy (A1, B1, and C1), and scanning electron
microscopy (A2, B2, and C2). The scale bar in each SEM image is 300 nm. Taken with permission of
ref 1.
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Initially, a colloidal AuNP suspension was deposited onto a PVP functionalized
glass substrate, and the nanoparticles were deformed by manually rolling a glass rod over
them (Figure 2.2A). When these AuNPs (before deformation) were illuminated with
white light, they appeared as bright green diffraction-limited points under a dark field
microscope. After deformation, however, these nanoparticles appeared red-colored in the
dark field image because their shape had changed from approximately spherical to
flattened discs, which altered the conditions for localized surface plasmon resonance.

Figure 2. 2: (A) Photograph of AuNPs on a glass slide being manually deformed with a glass stir
rod. A glass substrate coated with AuNPs is placed on a slide holder fixed to the optical bench to
hold it steady, and a glass stirring rod rolls over the AuNPs to flatten them. (B) A rolling pin,
comprising of a ¼″ glass tube with a metal pin through it, is held in a mechanical test system
fixture and rolled over particles deposited on a PVP functionalized ITO glass substrate. (C) Dark
field microscopy image showing both undeformed AuNP (bottom, green) and deformed AuNPs
(top, red) on a PVP functionalized glass substrate. 4X zoom in images of (D) deformed and (E)
undeformed AuNPs. Representative dark field single AuNP scattering spectra from (F) deformed
and (G) undeformed AuNPs. The squared AuNPs in figures (D) and (E) produced the spectra
shown in (F) and (G), respectively. Scale bar is 20 µm. Spectra are offset for clarity. Taken with
permission of ref 1.

Although nanoparticles can be easily deformed manually, this method suffers
from two major drawbacks: (i) the compressive force exerted on the nanoparticles may
not be uniform when the glass rod is manually rolled over the nanoparticles, and (ii) if the
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glass rod is not held properly, it could slide across the surface instead of rolling over it.
To apply a consistent and controllable compressive force to deform the nanoparticles, we
used a material testing stand (Model ESM 303, Mark-10 Corporation, Copiague NY,
USA) which pressed a glass "rolling pin" (a ¼ inch glass tube with a metal pin through it,
Figure 2.2B) against a nanoparticle-coated sample attached to a computer-controlled
stage.31 We deposited AuNPs onto a PVP functionalized glass substrate and mechanically
deformed them using the rolling pin (Figure 2.3).

Figure 2. 3: Photograph showing the deformation technique employed in this study. The rolling pin
was placed on one end of the slide to begin with. A mechanical force was applied by the ESM 303 as
the glass tube was rolled over the length of the glass substrate 10 times. The applied force was varied
from 0 to 50 N, and a constant rolling speed of 500 µm/s was used in each experiment. The glass tube
was cleaned several times using acetone and distilled water prior to use. Taken with permission of ref
1.
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The colloidal AuNPs (∼72 nm diameter as determined by SEM) dispersion used
in this experiment exhibited a strong extinction peak at around 520 nm (Figure 2.1). A
glass slide with undeformed and deformed AuNPs regions was imaged using dark field
microscopy; the undeformed particles at the bottom of the slide appeared as bright green
diffraction-limited spots, while the deformed particles at the top of the slide appeared red
as shown in Figure 2.2C. Dark field hyperspectral images showed single nanoparticles as
diffraction-limited spots for both the deformed (Figure 2.2D) and undeformed
(Figure 2.2E) AuNPs. In Figures 2.2D and E, four representative particles are labeled 1–
4, and their corresponding single-particle scattering spectra are shown
in Figures 2.2F and G, respectively. These results indicate that individual nanoparticles in
the ensemble have similar spectra to each other and that deformation causes a significant
red-shift from ∼565 nm to ∼760 nm. Our previous work showed similar results with
AgNPs; Figure 2.4 shows a comparison.31

Figure 2. 4: Dark field microscope image showing both deformed (top-red) and undeformed (bottomblue) regions of Ag NPs on a glass/ITO slide. Taken with permission of ref 1.
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The undeformed (Figure 2.5A1) and deformed AuNPs (Figures 2.5B1 and C1)
were imaged using SEM. Figures 2.5A2, B2 and C2 show the corresponding histograms,
which revealed the effective nanoparticle diameter for the undeformed and deformed
AuNPs (calculated from the area of each particle assuming a disc shape). The SEM
images revealed that the AuNPs diameter and shapes varied as the applied load increased.
The unmodified AuNPs had a roughly spherical shape with a mean diameter of 72 nm
and a 6.9% of the coefficient of variation (CV), Figure 2.5A. Rolling over the particles
caused them to deform from spheres into discs and their mean diameters to increase in a
load-dependent manner, increasing to 173 nm (CV-5.8%) with a 30 N load and 183 nm
(CV-13%) with a 50 N load.
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Figure 2. 5: (Left) SEM images showing effect of applied load (A1) 0 N, (B1) 30 N, and (C1) 50 N on
deformation of AuNPs. All images have the same magnification (Scale bar is 300 nm). Histograms on
the right of each SEM image show particle diameter distributions for (A2) undeformed and (B2, C2)
deformed AuNPs. The sample preparation and SEM imaging procedure are described in the
Experimental Section. The inset numbers show estimated mean diameter and uncertainty from a
Gaussian fit. (D1) Average dark field single nanoparticle scattering spectra of one hundred
undeformed and deformed AuNPs as a function of applied load (0, 1, 3, 5, 8, 10, 30, 50 N). The
spectra are scaled to the same maximum intensity. (D2) Experimental data on the evolution of LSPR
peak position, before and after deformation, as a function of applied load. Figure 2.6 shows a
comparison with our previous AgNP study. Taken with permission of ref 1.
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Figure 2. 6: Average dark field single nanoparticle scattering spectra of un-deformed and
deformed (A) AgNPs and(C) AuNPs as a function of applied load. The spectra are scaled to the
same maximum intensity. Experimental data on the evolution of LSPR peak position, before and
after deformation of (B) AgNPs and (D) AuNPs as a function of applied load. Panels A and B are
adapted from reference.31 Taken with permission of ref 1.

In our previous study, the deformation of AgNPs produced mostly ellipse-shaped
nanodiscs35 with some sharp features, while the deformed AuNPs produced in this study
were more circular nanodiscs according to the SEM images. This difference in shapes is
attributed to the high crystallinity nature of AgNPs35, which may have resulted in
different deformation along different crystalline axes.36 In contrast, the AuNPs exhibited
smaller crystal domain sizes with no preferred deformation axes. Further, at lower
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particle concentrations where individual particles could be resolved, the ellipse-shaped
silver nanodiscs produced show polarization-dependent scattering properties (Figure 2.7).
The random orientation and polarization dependence, along with random nanoparticle
positioning and color, are important for making unique irreproducible patterns for anticounterfeiting/tamper-proof applications for uncirculated mint coins and electronic
components legal documents, etc.37–39 For these applications, stamp patterning is helpful
for rapidly identifying a region of interest with the nanoparticles on it. After deformation,
both Ag and AuNPs remain well-separated (except at higher concentrations where
particles begin to touch).

Figure 2. 7: (A) Dark field microscope image of patterned/deformed Ag NPs by placing TEM grid
on NPs and mechanically pressing them. (B) Dark field microscope images (Zoomed in) of
location 1,2 and 3 by placing polarizer at 0 (zero) and 90 degrees of angle. NPs marked using
yellow color boxes show polarization dependent scattering properties. Some of the NPs at location
3 shows shape and orientation dependent scattering. Taken with permission of ref 1.
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We next studied the LSPR properties of the undeformed and deformed AuNPs by
recording the dark field single nanoparticle scattering spectra for undeformed and
deformed AuNPs on the glass substrate, as shown in Figure 2.5D1. The LSPR peak redshifts and broadens with increasing applied load due to the increasing AuNP diameter
and associated change in the aspect ratio (diameter/height). An overall LSPR shift of
∼195 nm was observed when the applied load increased from 0 to 50 N, implying that
the LSPR could be systematically red-shifted with increasing force and shape change.
The data in Figure 2.5D2 illustrate the correlation between the maximum LSPR
wavelength of undeformed and deformed AuNPs and applied load. The maximum LSPR
wavelength increases rapidly with load for applied loads below between 0 and 10 N, after
which the rate of red-shift decreases when the applied load is varied from 10 to 50 N.
This is in part due to a slower increase in the nanoparticle diameter relative to the initial
NP diameter. Similarly, the glass rolling pin deforms slightly (on a < 100 nm scale) with
pressure, increasing the contact area with adjacent particles and glass substrate, thus
exerting less force on each particle.31 In addition to the deformation not scaling with
force, the spectral shift is not expected to scale with force either because the phase of the
incident light varies across the AuNPs, requiring consideration of dynamic depolarization
and retardation effects.40–44 Similar to preparing nanodiscs, nanorods can be prepared. A
preliminary study carried out to prepare nanorods is described in chapter 6.
2.4.2. Stamping deformation pattern
To rapidly generate patterns of deformed plasmonic nanoparticles, a stamp can be
placed between the rolling pin and nanoparticles. To show this principle, we used TEM

47

grids (SPI supplies, Crosby, TX) and VACCO grids (precision etched parts, South EI
Monte, CA) as stamps. TEM grids have a grid pattern on which samples are typically
deposited prior to imaging, with the grid designed to select sample areas rapidly; these
grids have uniform heights and precise boundaries, are relatively inexpensive, and can be
bought in large quantities. VACCO grids are designed as demo pieces to show the
capability to etch patterned metal substrates for a wide range of applications, from
physical filters to fluid control products (regulators and valves). The VACCO grids were
larger than the TEM grids, had a rougher surface, and were reused several times in our
experiments. We first performed the experiment by manually rolling a glass stir bar over
either TEM or VACCO grids to press it into the silver nanoparticle covered glass slide.
For the relatively large VACCO grid, the deformation pattern can be observed clearly by
eye (Figure 2.8). The sample in Figure 2.8 was made and photographed during a public
outreach event, Upstate !MAGINE Greenville, South Carolina, which exemplifies the
simplicity of the technique and its potential applicability to science demos and potentially
for printing and artistic applications.

Figure 2. 8: Photographs of glass slide coated with AgNPs, with stamp patterns formed by
manually pressing either at TEM grid or VACCO grid onto the slide with a rolling pin. The blue
color is a result of light scattering by the undeformed particles, and the red regions represent
scattered light by the deformed particles. The stamping and imaging were performed by
volunteers during the Upstate EMAG!NE public education outreach event in Greenville, South
Carolina. The vertical streaks are the scratched marks caused by the rolling rod on the
microscope slide. Taken with permission of ref 1.
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For more precise work, the mechanical test system was used to apply a uniform
force. Figure 2.9 shows how deformed and undeformed areas can be easily distinguished
by dark field microscopy, SEM (Figure 2.10A), and AFM (Figure 2.10B1 and B2).
Nanoparticles in the deformed regions were disc-shaped and had a larger diameter and
smaller height than the undeformed, approximately spherical (or polygonal)
nanoparticles. The boundary between deformed and undeformed nanoparticles was very
close to a straight line; occasionally, a nanoparticle was found on the boundary itself and
was deformed only where the grid was in contact with a region of the particle that
remained unflattened (e.g., Figures 2.9B3). These observations were confirmed by AFM
topographic scanning (Figure 2.10C1-C3) using AgNPs. The zoom-out AFM image
(20 × 20 microns) shows that under the mechanical force, the original polygonal AgNPs
(∼97 nm) were uniformly deformed into flatted particles (∼24 nm height, Figure 2.11).
Interestingly, AgNPs located at the border between original AgNPs and deformed AgNPs
were partially deformed, with one part of the particle essentially unchanged, while the
part under pressure was flattened (larger diameter and reduced height)
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Figure 2. 9: Patterning with TEM grid pattern. (i-iii) Schematic illustration of the principle of the
patterning technique. The patterning technique involves three steps: (i) Deposition of
nanoparticles on PVP functionalized glass slides, (ii) Patterning of selected nanoparticles via
mechanical deformation using a TEM grid as a stamp (not drawn to scale), and (iii) Lift-off of
TEM grid from sample surface, which leaves deformed nanoparticles in shape of the TEM-grid
pattern. Images of Au (middle row) and Ag (bottom row) NPs deformed under a copper TEMgrid pattern. (A1, B1) Hyperspectral dark field images and (A2, A3, B2, B3) SEM images. Both
undeformed and deformed regions were marked using a dashed line. (A4, B4) Representative
average dark field scattering spectrum from un-deformed and deformed Au and Ag NPs regions,
respectively. Taken with permission of ref 1.
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Figure 2. 10: (A) SEM image showing both deformed (right to dotted line) and undeformed (left
to dotted line) regions of Ag NPs on an ITO slide. The number of particles per unit area is
unchanged before and after deformation (~10 particles/µm2). (B1-B2) AFM images of AgNPs
deformed under a copper TEM grid pattern. Contact AFM was used to map the profiles of
patterned AgNPs on PVP-functionalized ITO glass substrates by applying 50 N load. Partly
deformed individual Ag nanoparticles. (C1) 2D and (C2) 3D AFM images showing boundary
between deformed and undeformed AgNPs. (C3) Zoom in image showing a single nanoparticle
that was partly deformed. Taken with permission of ref 1.
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Figure 2. 11: Histograms of the average AgNPs height (A) before and (B) after deforming using
TEM grid. All AFM height measurements were obtained based on more than at least 150
particles. Taken with permission of ref 1.

The pattern was controlled by the stamp shape. If the stamp surface was uneven,
the pattern reproduced some of the stamp features on the nanoparticle deformation
pattern. For example, in place of a smooth copper TEM grid, a hexagonal patterned metal
grid from VACCO was used as a stamp to deform ∼100 nm silver nanoparticles. The
stamp finishing produced an uneven finish with clear streaks along one axis

(Figure 2.12A1), causing ∼200 nm height variation along 20 µm laterally, as shown in

Figure 4A2. This caused similar features in the deformation (Figures 2.12B1 and B2) of
Au and (Figures 2.12C1 and C2) AgNPs. This experiment demonstrates that stamps with
smooth surfaces are needed to generate uniformly deformed nanoparticles and that the
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surface height changes present in the stamp can be transferred to the deformed
nanoparticle pattern, which can be visualized both optically and using AFM.

Figure 2. 12: (A1) Optical profiler image of VACCO grid showing parallel streaks, (A2) zoom in
image of (A1). (A3) 3D AFM image showing surface roughness (ridges and grooves) of VACCO
grid. Dark field microscope images of deformed regions of (B1) AuNPs and (C1) AgNPs. Zoom in
images of (B2) AuNPs and (C2) AgNPs from B1 and C1 showing printed parallel streaks and
surface roughness (green (B2) and blue (C2) areas in deformed regions are due to grooves of
VACCO grid). 3D AFM images of (B2) AuNPs and (C2) AgNPs deformed using the hexagonal
patterned VACCO grid. Taken with permission of ref 1.

Individual nanoparticles with rougher features imprinted on them may be useful
in applications such as sensors and catalysis and other applications that could benefit
from the relatively larger surface area when compared to that of the nanoparticle with
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smoother features (Figure 2.13). A preliminary study carried out to identify potential
catalysis applications is described in chapter 6.

Figure 2. 13: High resolution AFM images in (A) 2D and (B) 3D. Areas within the white circles
show the deformed nanoparticles caused by the ridges in the hexagonal stamp (see Figure 4).
Taken with permission of ref 1.

AuNPs were also patterned by depositing glucose crystals to create circular points
of undeformed NPs regions. Glucose crystals were deposited by dusting over AuNPs
coated glass slide and then blowing off excess crystals. Then, the patterns were generated
by rolling a glass rolling pin attached to the Mark-10 force gauge (Figure 2.14). Patterns
were observed under dark field microscope; the glucose crystals were honored at the
center of the circular undeformed NPs region, which appears blue. AuNPs away from the
glucose appears red due to the complete deformation of NPs, and at the boundary of blue
and red areas, there are two circles in green and yellow colors due to partial deformation
of NPs. When it goes away from the glucose deposit λmax of the dark field, single
nanoparticle scattering spectra shift to the red region of the wavelength (Figure 2.14B).
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Further, the SEM image showed the increase in NPs diameter when it goes away from the
glucose deposit (Figure 2.14C).

Figure 2. 14: (A) Hyperspectral dark field image showing protected region of Ag NPs around the
glucose deposit and deformed region away from the deposit. (B) Dark field single nanoparticle
scattering spectra of undeformed (blue region), partially deformed (green and yellow regions)
and deformed (red region) NPs corresponding to image (A). (C) Scanning electron microscopic
image of patterned Ag NPs.

For some applications, such as printing non-bleaching colorants, it would be
useful to generate patterns of only deformed particles with dark nanoparticle-free regions.
We found that simple adhesive tape could remove undeformed particles from the
substrate. Figures 2.15(i, ii, iii) illustrate the principle of this method schematically.
Figures 5A1 and B1 show hyperspectral dark field images of AuNPs and AgNPs
deformed under a copper TEM-grid pattern, respectively. The deformed and undeformed
areas can be clearly distinguished in these images. Figures 2.15A2, A3, and B2, B3 show
the hyperspectral dark field images of patterned AuNPs and AgNPs after removing
undeformed NPs using adhesive tape, respectively. This figure further confirms that this
method is an effective way to remove undeformed nanoparticles from the surfaces and
make patterned nanoparticle substrates. Furthermore, the approach also generated clear
patterns without residues between lines (Figure 2.15B3). The preferential removal of
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undeformed spherical particles was likely due to the small contact area between the
spheres and surface compared to the much larger contact area after deformation.

Figure 2. 15: i-iii, Schematic illustration of the removal of undeformed nanoparticles using
adhesive tape. (i) Mechanically deformed nanoparticles; (ii) applying adhesive tape on the
patterned glass substrate to peel-off undeformed NPs; (iii) pattern of deformed pa particles left
on the glass slide. (A1-A3) Hyperspectral dark field images of AuNPs deformed with a TEM grid;
(B1-B3) hyperspectral dark field images of AgNPs deformed with a TEM grid. (A1, B1) Pattern
before removing undeformed particles; (A2, B2) pattern after removal of undeformed NPs with
adhesive tape; (A3, B3) 40X zoom in images of patterned AuNPs and Ag NPs from A2 and C3.
Taken with permission of ref 1.

Scotch tape has previously been used to capture NPs such as Ag, Au, Cu and Pd
onto a flexible surface45 for numerous applications, including point of care detection of
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bacterial infections and to detect pesticides on fruits and vegetables using Surface
Enhanced Raman Spectroscopy (SERS).45,46 Although the scotch can provide a
background signal in these sensing applications; the analyte can be distinguished and
detected. There was no noticeable residue from the tape in the dark field images or
electron microscopy and AFM images; however, it is possible that a thin residue could be
left behind, which could provide a background signal in sensing applications that would
require either chemical removal (e.g., alcohol washing) or plasma treatment.
Patterned nanoparticle arrays could also be transferred to a flexible polymer
surface. We used First Contact Polymer (Platteville, WI) which is generally used to
remove dust, fingerprints, residues and contaminants from precision surfaces such as
lenses. Clear First Contact Polymer is a colorless solution that dries into a flexible thinfilm at room temperature, and can be peeled off easily. Moreover, it can be either
stretched or bent, and after the force is removed its original shape and size are restored
(Figure 2.16A1-A3).
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Figure 2. 16: Transferring AgNPs to flexible polymer films. (A1) First ContactTM clear polymer
polymerized into a thin-film on a glass slide. (A2) Peeling off, and (A3) stretching of the clear
thin-film. Dark field microscope images (100 x oil, immersion) of (B1) patterned and undeformed
Ag NPs on a glass slide, (B2) patterned and undeformed Ag NPs remaining on glass slide after
removing NPs using a thin film. Taken with permission of ref 1.

By applying liquid polymer onto the patterned region and allowing it to dry, the
NPs can be transferred onto the polymer surface. When the polymer solution is dried fast
(within 5 minutes) on a NPs coated glass slide, the undeformed NPs are transferred onto
the thin film, leaving deformed NPs on the glass slide (Figure 2.17B i-iii). When the
polymer solution is dried slowly (dried within 30 minutes), both undeformed and
deformed NPs are transferred onto the thin film (Figure 2.17C i-iii). The slower
evaporation results in uniform, resilient and good quality thin film that is in contact with
the top and sides of the NPs, including any overhang. Before transferring NPs onto thin
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film, about 10 particles per μm2 were present (forming continuous colored regions in the
diffraction-limited dark field images but countable in SEM images); after transferring the
NPs the remaining particles on the glass slide could be clearly distinguished and counted
in dark field imaging and had a concentration of ∼0.6 particles per μm2 (Figure 2.16B12). After removing undeformed NPs using a scotch tape, the deformed nanoparticles in

the patterned region can also be transferred onto a polymer surface (Figure 2.17D i-iii).
Both clear and red First Contact Polymer can be used to remove nanoparticles.
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Figure 2. 17:A i-A iii, Schematic illustration of the transfer of NPs onto a clear polymer-film. (A i)
Patterned and undeformed NPs on glass slide; (A ii) applying Clear First Contact polymer, letting
it dry and peeling off (NPs transferred onto the polymer-film); (A iii) NPs remained on the glass
slide. Dark field microscope images of patterned and undeformed NPs on (B i) glass slide and (B
ii) undeformed NPs on polymer-film, (B iii) remaining NPs on the glass slide. Dark field
microscope images of patterned and undeformed NPs on (C i) glass slide and (C ii) on polymerfilm, (C iii) remaining NPs on the glass slide. Dark field microscope images of patterned NPs on
(D i) glass slide after removing undeformed NPs and (D ii) patterned NPs on polymer-film, (D iii)
remaining NPs on the glass slide. Taken with permission of ref 1.
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2.5. Conclusions
We demonstrated a simple method to pattern gold and silver nanoparticles and
controlled their shapes by pressing a stamp onto the coating of the particles on a glass
substrate. The resulting nanoparticle shape change induces a red-shift in the localized
surface plasmon resonance, while regions untouched by the stamp remain unchanged.
Using this method, we demonstrated that a single nanoparticle can be partially patterned
or deformed. Furthermore, (i) regions with only deformed nanoparticles present on the
glass substrate can be prepared by removing undeformed nanoparticles with a tape, and
(ii) patterns of both deformed and undeformed nanoparticles can be transferred onto a
thin polymer film. This is a simple, inexpensive, and yet effective technique to control
the size and shape via patterning to tune the optical properties of nanoparticles. Future
work will involve studying how changes in the nanoparticle surface roughness influence
the catalytic and sensing properties of AuNPs and AgNPs.
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CHAPTER THREE
X-RAY EXCITED LUMINESCENCE SPECTROSCOPY AND IMAGING WITH
NaGdF4:Eu AND Tb
Much of the material in this chapter was published as a journal article: Ranasinghe, M.;
Arifuzzaman, M.; Rajamanthrilage, A. C.; Dickey, A.; Kolis, J. W.; Bolding, M.; Anker, J.
X-Ray Excited Luminescence Spectroscopy and Imaging with NaGdF4:Eu and Tb. 2020.
RSC Adv., 2021, 11, 31717-31726. https://doi.org/10.1039/D1RA05451A.
3.1. Abstract
Like plasmonic nanoparticles, X-ray luminescence nanoparticles also have
interesting optical properties (in this case X-ray excited optical luminescence) and can be
functionalized with biomolecules to use in bioimaging and sensing applications. The
intensity of optical X-ray excited optical luminescence is dependent on the nanoparticle
size, host matrix, crystallinity, activator and impurity concentrations, etc. X-ray excited
optical luminescence from nanophosphors can be used to selectively generate light in
tissue for imaging and stimulating light-responsive materials and cells. Herein, we
synthesized X-ray scintillating NaGdF4:Eu and Tb nanophosphors via co-precipitate and
hydrothermal methods, encapsulated with silica, functionalized with biotin, and
characterized by X-ray excited optical luminescence spectroscopy and imaging. The
nanophosphors synthesized by the co-precipitate method were ∼90 and ∼106 nm in

diameter, respectively, with hydrothermally synthesized particles showing the highest
luminescence intensity. More importantly, we investigated the effect of thermal
annealing/calcination on the X-ray excited luminescence spectra and intensity. At above
1000 °C, the luminescence intensity increased, but particles fused together. Coating with
a 15 nm thick silica shell prevented particle fusion and enabled silane-based chemical
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functionalization, although luminescence decreased largely due to the increased mass of
non-luminescent material. We observed an increase in luminesce intensity with
temperature until 400 °C. At above 600 °C, NaGdF4:Eu@SiO2 converts to
NaGd9Si6O26:Eu, an X-ray scintillator brighter than annealed NPs at 400 °C and dimmer
than NPs synthesized using the hydrothermal method. The particles generate light
through tissue and can be selectively excited using a focused X-ray source for imaging
and light generation applications. The particles also act as MRI contrast agents for multimodal localization.

3.2. Introduction
Light can be a powerful tool for studying biochemistry in cells and tissue and for
stimulating responses from genetically engineered light-sensitive neurons (optogenetics)
or photo-released drugs. The challenge for delivering or retrieving light from deep tissue
is that scattering in the tissue prevents light from traveling ballistically, and the point
spread function is typically >1 cm through 1 cm of tissue; also, the light is attenuated by
the tissue.1,2 One approach that circumvents these problems is to use selectively generate
light using focused X-ray beams to generate visible luminescence from scintillators
implanted or injected in the tissue. Since X-rays are far less scattered than visible and
near-infrared light, the X-ray beam focus can be maintained through the tissue and
generate visible light locally after absorption by scintillator particles. Scintillators are
luminescent materials that absorb high-energy radiation (γ- and X-ray photons, high
energy ions, neutrons, or other subatomic particles) and emit UV, visible and/or NIR
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light.1,2 These materials are widely used in radiation detection3 and imaging
applications,4–6 and occasionally in external power-free light generation applications
(e.g., old luminescent watches, emergency lighting, and gun sites).7 Recently, researchers
have been developing scintillator nanophosphors for improved X-ray luminescence
imaging,8–10 radiation imaging,9,11,12, and as a potential light source for photochemistry
and photobiology (e.g., X-ray excited optogenetics13).
Rare-earth doped materials (NaGdF4:Eu14,15 and Tb,16 Gd2O2S:Eu and
Tb,10 YAG:Nd, LuAG:Tm, Lu2SiO5:Ce17) have interesting properties, including narrow
and distinct spectral emission peaks, large optical penetration depth, negligible
autofluorescence background, photochemical stability, and low toxicity.6 Among them,
rare-earth fluorides (NaGdF4) are considered excellent host matrices for luminescent rare
earth elements (e.g., Eu and Tb). They usually have high refractive indices and low
phonon energies, which cause a low probability of nonradiative decay and higher
luminescent quantum yields compared to oxide hosts and other inorganic matrices.18
Herein, we synthesize 100 nm diameter NaGdF4:Eu and NaGdF4:Tb
nanophosphors for X-ray excited luminescence. This diameter is in a good range for long
circulation as nanoparticles smaller than ∼5.5 nm undergo relatively fast blood clearance
by renal filtration, nanoparticles smaller than ∼70 nm filter through fenestrae of hepatic

sinusoids,19–21 while nanoparticles between 200–500 nm are endocytosed by phagocytic
or non-phagocytic cells and nanoparticles larger than 500 nm are likely to remove from
cells by phagocytosis.19–22 Thus, nanoparticles with 100 nm diameter have shown the
minimum effect on blood clearance mechanisms (e.g., renal, liver filtration) and
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prolonged circulation time.20,21 These intermediate-size nanoparticles tend to accumulate
in perivascular spaces of permeable tissues (e.g., liver and spleen, tumor, site of
inflammation and angiogenesis)19,20 allowing bicomponent imaging.
We also compared X-ray excited optical luminescence (XEOL) spectra from
hydrothermal and co-precipitation synthesis methods and the effect of thermal annealing.
Nanoparticle annealing at high temperature is a widespread method in upconversion
nanophosphors to enhance luminescence10,23,24 by reducing crystal defect, increasing
crystal domain size, and removing trapped water and carbon dioxide. However,
enhancing luminescence of X-ray excited nanophosphors using annealing techniques is
still under investigation. Here, we synthesized both NaGdF4:Tb and NaGdF4:Eu, which
have distinct spectra. The nanophosphors were functionalized with biotin and attached to
streptavidin in vitro. They could be selectively excited in a solution using a focused Xray source to obtain XEOL spectroscopy and image through tissue; here, we focused on
the NaGdF4:Eu because their red emission has deeper penetration through tissue than the
largely green-emitting NaGdF4:Tb.25,26 Additionally, the particles serve as T1 and T2 MRI
contrast agents, useful for multi-modal imaging applications.

3.3. Methods
3.3.1. NaGdF4:Eu and NaGdF4:Tb nanoparticle synthesis
We synthesized particles using either the co-precipitation or hydrothermal
synthesis methods.
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Co-precipitate synthesis method. NaGdF4:Eu and Tb nanophosphors were
synthesized by the citrate method with slight modifications.14,27 Sodium citrate (12 mL of
0.2 M) was added to a clear aqueous solution containing 4 mL of Gd(NO3)3 (0.2 M) and
Tb(NO3)3/Eu(NO3)3 (X mol%) and stirred vigorously for 30 min at room temperature.
Then, 16 mL of sodium fluoride (1 M) solution was combined with the above mixture
and stirred vigorously for another 2 hours which result in a white solution. The
synthesized nanophosphors were centrifuged and washed three times before further
experiments. (Tb(NO3)3/Eu(NO3)3 X mol% = 0.1%, 1%, 15% 20%, 100% of
Gd3+ moles).
Hydrothermal synthesis method. NaGdF4:Eu and Tb nanophosphors were
synthesized by the citrate method with slight modifications.14,15,27 Sodium citrate (12 mL
of 0.2 M) was added to a clear aqueous solution containing 4 mL of GdNO3 (0.2 M) and
Tb(NO3)3/Eu(NO3)3 (X mol%) and stirred for 30 min. Then, 16 mL of sodium fluoride (1
M) solution was combined with the above mixture and stirred vigorously for another 15
minutes which result in a white solution. This solution was transferred to a Teflon-lined
autoclave and heated at 180 °C for 6 hours. The synthesized nanophosphors were
centrifuged and washed three times before further experiments. The synthesized
nanophosphors were stored in either DI water or 0.1% citrate solution.
(Tb(NO3)3/Eu(NO3)3 X mol% = 0.1%, 1%, 15% 20%, 100% of Gd3+ moles).
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3.3.2. Silica coating NaGdF4:Eu and Tb nanoparticles
Synthesized nanophosphors were coated with silica using previously described
methods28–30 with slight modifications (certain reagents were scaled up). Eu doped and
Tb doped NaGdF4 nanoparticles prepared at room temperature were resuspended in 8 mL
of water and combined with 200 mL ethanol solution containing PVP (1.2 g) and
ammonium hydroxide (6 mL). Then, TEOS (160 μL) was added after the solution was
stirred for 20 min. The particles were aged another 3 hours before centrifuged and
washed using DI water.
3.3.3. Annealing NaGdF4:Eu nanoparticles
NaGdF4:Eu nanoparticles prepared using the co-precipitate method were dried at
80 °C to form a white powder. It was transferred to a crucible and heated (10 °C min−1) at
1000 °C for 6 hours in a muffle furnace which results in a solid, aggregated structure.
After cooling down to room temperature, it was crushed into a fine powder using mortar
and pestle.
NaGdF4:Eu@SiO2 nanophosphors were dried at 80 °C to form a white powder
and divide into three portions and transferred to crucibles. The samples were heated at
400 °C, 600 °C and 1000 °C for 6 hours to anneal them.
3.3.4. Functionalization of NaGdF4:Eu@SiO2 with biotin
NaGdF4:Eu@SiO2 nanophosphors were resuspended in ethanol (100 mL) with
APTES (300 μL) and stirred for 3.5 h. The amine-functionalized nanophosphors were
collected and washed three times using DI water.
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98 mL of MES buffer (0.1 M, pH 6.0) was taken in a 500 mL round bottom flask.
∼100 mg of water-soluble carbodiimide (EDC) and sulfo-NHS was added to it and

stirred for 15 minutes at room temperature. H2PO4–PEG–COOH (5000 Da) (500 μL, 10
mg mL−1) and biotin–PEG–COOH (1000 Da) (250 μL, 10 mg mL−1) was added to the
above solution and stirred for 1 hour at room temperature to activate COOH groups.
Then, the solution pH was adjusted to pH 7.4 using PBS buffer. Previously prepared
NH2 functionalized NaGdF4:Eu@SiO2 nanoparticles were added to the mixture and it
could react for 12 h at room temperature with continuous stirring. Lastly, biotinconjugated NPs were washed with PBS three times and stored in DI water.
Biotin functionalized aqueous nanophosphors suspension (10 mg mL−1, 20 μL)
was transferred into a centrifuge tube contained PBS (10×, 380 μL) solution.
Streptavidin-coated microbubbles (100 μL) were mixed with the previous solution and
vortexed to allow particle adhesion on the surface of the microbubble. After waiting a
10–15 minutes, suspended microbubbles were pipetted out and washed three times with
DI water.31,32

3.3.5. Dark field optical imaging capillaries filled with NaGdF4:Eu through
tissue
A series of concentration of NaGdF4:Eu (100, 50 and 0 mg mL−1) was prepared
and filled in 1 mm (inner diameter) capillaries.
X-ray excited optical luminescence of all the samples in capillaries were
measured by irradiating with a Mini-X Ag-target X-ray source at 40 kV and 99 μA.
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Spectral data of capillaries were obtained at 10 s exposure time and capillaries
sandwiched in between 4 mm porcine tissue were obtained at 60 s exposure time.
X-ray excited luminescence chemical imaging (XELCI) of these capillaries was
done without tissue and with 5 mm porcine tissue. The capillaries were scanned with 250
μm step size and 1 mm s−1 for a high-resolution scan. For imaging without tissue, the Xray source was set to 50 kV and 200 μA; 50 kV and 600 μA was used for imaging with
porcine tissue. Data were analyzed and plotted using custom MATLAB scripts.

3.3.6. MR imaging of NaGdF4:Eu and Tb
Solutions of NaGdF4:Eu and Tb nanophosphors at a series of concentrations from
0 to 0.4 mM were prepared by dissolving in DI water. MR imaging and relaxometry was
done on a 3T Siemens MAGNATOM Prisma MRI instrument (Siemens Healthineers,
Erlangen, Germany). T1-weighted images were acquired using a 2D spin echo sequence
with repetition time (TR) 25 ms and echo time (TE) 5.9 ms. T2-weighted images were
acquired using a turbo spin echo sequence with TR = 3200 ms and TE = 29 ms. T1 was
measured with an inversion recovery experiment using a spin echo pulse sequence.
Inversion times (TI) were 25, 50, 400, 1100, and 2500 ms. To calculate T1, the model
from ref. 33 was fit to MR signal magnitude vs. TI using the qMRLab package for
MATLAB.34 T2 was measured with a multi-echo spin echo sequence using 32 TEs
ranging from 15 to 960 ms. To calculate T2, a monoexponential model 𝑆𝑆(𝑇𝑇𝑇𝑇) =

𝑀𝑀0 exp �−

𝑇𝑇𝑇𝑇
𝑇𝑇2

�

was fit to MR signal magnitude vs. TE. Relaxivities were calculated by

linear regression of R1 = 1/T1, R2 = 1/T2 vs. nanoparticle concentration.
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3.3.7. Transmission electron microscopy
The synthesized, silica-coated and annealed nanoparticles were deposited on a
formvar/carbon-coated copper grids from a water solution and dried before taking the
transmission electron micrographs from Hitachi HT7800 operating at 20–120 keV and 8
μA.
3.3.8. Powder X-ray diffraction (XRD)
The phases of the NaGdF4:Eu powders, nanoparticles, and annealed nanoparticles
were characterized by Rigaku Ultima IV powder diffractometer, using Cu Kα radiation.
Powdered samples were spread on a low background glass slide and data are collected in
0.02° increments at a rate of 0.5–1° per minute from 10° to 70° at room temperature.
Annealed particles were measured at 0.2–0.5° per minute.
3.3.9. X-ray excited optical luminescence (XEOL) spectroscopy
X-ray luminescence of all the nanoparticles was measured by irradiating with an
X-ray beam. A 96 well plate containing dried and powdered nanoparticles was places on
the stage of an inverted microscope (Leica microscope) and irradiated with an X-ray
beam generated using a Mini-X (Ag) X-ray source (Amptek, Bedford, MA) set at 40 kV
and 99 μA. The emission of nanoparticles was collected by 5x objective and focused to a
spectrograph (DNS 300, DeltaNu, Laramie, WY, USA), equipped with a cooled CCD
camera (iDUS-420BV, Andor, South Windsor, CT, United States).
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3.3.10. ICP-OES metal analysis
The percentage of metals (Gd, Eu and Tb) in the final systems were measured
using iCAP 7200 MSC ICP-OES analyzer. Nanophosphors were dissolved in 2%
HNO3 to prepare nitrates of the metals. The standard metal solutions were prepared from
0.1 to 100 ppm range. The samples and the standards were injected to ICP-OES and
quantified the amount of metal using instrument software (Qtegra ISDS software). The
wavelengths of the corresponding spectrometric lines that used for the analysis were Gd:
335 nm, Eu: 381 nm, Tb: 350 nm. The metal percentages (Eu/Gd and Tb/Gd) from the
dissolved samples were calculated using standard curves.
3.3.11. Thermal analysis: TGA/DSC
TGA and DSC measurements were carried out on a SDT Q600 V20.9 Build 20
thermal gravimetric by TA instruments. Nanophosphor samples in alumina crucibles
were heated up to 700 °C at a rate of 20 °C minute−1 under N2 gas flow. At 700 °C
samples were kept under isothermal conditions and flushed with air. TGA and DSC
measurements were collected simultaneously.

3.4. Results and Discussion
We synthesized NaGdF4:Eu and NaGdF4:Tb nanophosphors via co-precipitation
and hydrothermal methods and studied the effect of dopant concentration on their optical
spectra and crystal diffraction patterns. Next, we encapsulated the nanophosphors in
silica to prevent thermal sintering and studied the effect of thermal treatment. We
functionalized the nanophosphors with biotin and showed that we could excite colloidal
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suspensions of particles with a focused X-ray beam to image the luminescence through
tissue. Finally, we explored the possibility of multimodal imaging based on spectrally
distinct features of the nanophosphors and MRI contrast.
3.4.1. NaGdF4:Eu and NaGdF4:Tb nanoparticle synthesis
In the NaGdF4 nanophosphor synthesis, citrate acts as a complexing and
dispersing agent that forms a La3+–Cit3− complex and disperses in deionized (DI) water.
Upon addition of excess NaF, La3+ released from the complex reacts with Na+ and F− to
form NaGdF4 nuclei. After forming NaGdF4:Eu and Tb, the citrate serves as a surfactant
that controls nanoparticle growth and prevents aggregation.15,35
Co-precipitate synthesis method. The co-precipitate synthesis process is
presented in Figure 3.1A. The nanophosphors synthesized using the co-precipitate
method at room temperature were approximately spherical in shape (Figure 3.1B1 and
C1). The Eu-doped and Tb-doped nanophosphors respectivly had average diameters of
∼90 nm (Figure 3.1A2) and 106 nm (Figure 3.1C2), respectively. The powder X-ray
diffraction (powder-XRD) peaks displayed the presence of cubic (β-phase)

NaGdF4 (Figure 3.1B3 and C3) indexed to the standard data (JCPDS 00-027-0699), with
relatively large peak with indicating small crystal domain sizes (∼55 Å NaGdF4:Eu and
∼53 Å NaGdF4:Tb according to the Scherrer equation based on peak at 16.8 degrees).
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Figure 3. 1: (A) Schematic illustration of nanophosphors synthesis according to co-precipitate method. (i)
Mixture of Gd(NO3)3 and Eu(NO3)3 or Tb(NO3)3, (ii) Ln3+–citrate3− complex appears as a clear solution,
(iii) formation of NaGdF4:Ln3+ nanophosphors. Zoom out TEM images of (B1) NaGdF4:Eu and (C1)
NaGdF4:Tb nanophosphors. Zoom in TEM images of (B2) NaGdF4:Eu and (C2) NaGdF4:Tb
nanophosphors. Histograms of the average diameter of (B3) NaGdF4:Eu and (C3) NaGdF4:Tb. Powder
XRD pattern compared to PDF cards 27-0699 of (B4) NaGdF4:Eu and (C4) NaGdF4:Tb. Taken with
permission of ref 1.
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TEM images and powder-XRD patterns of Eu- and Tb-dopped NaGdF4 (0.1, 1,
15, 20 and 100%) are included in figure 3.2.

Figure 3. 2: TEM images of NaGdF4 doped with (i) 0.1%, (ii) 1%,(iii) 15%,(iv) 20%,(v) 100% Eu
synthesized using the co-precipitate method. Scale bar is equal to 100 nm. XRD patterns of (A) Eu
and (B) Tb-doped NaGdF4 (Gd: dopant molar ratio= 1: 0.1, 1, 15, 20, 100%). XRD data were
collected using single-crystal XRD as an alternative of powder XRD. PDF card is 27-0699. Taken
with permission of ref 1.

The synthesized nanophosphors show powder-XRD peak shift compared to
standard peak positions (e.g., peaks at around 53° in Figure 3.1). This observation is
common in most powder-XRD patterns due to changes in stoichiometric composition by
doping (size and amount of dopant), microstructure parameters (crystallite size and lattice
strain).36 X-ray luminescence nanophosphors with low emission intensity are used in Xray luminescence computer tomography (XLCT) and focused X-ray luminescence
tomography (FXLT).11
The optical properties of rare-earth-doped nanophosphors depend upon the doping
ions and crystalline matrix. Figure 3.3 shows the X-ray excited optical luminescence
spectrum of NaGdF4:Eu. There are three characteristic peaks in the visible range of the
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electromagnetic spectrum, at around 589 nm, 615 nm, and 691 nm, that correspond
to 5D0 → 7F1, 5D0 → 7F2, 5D0 → 7F4 transitions.10,14 Tb doped NaGdF4 has four
characteristic peaks in the visible range, at around 489 nm, 543 nm, 585 nm, and 620 nm
corresponding to 5D4 → 7F6 5D4 → 7F5, 5D4 → 7F4, 5D4 → 7F3 transitions.10,37 Since the
luminescence intensity depends upon dopant concentration,38,39 we varied the amount of
Eu and Tb compared to Gd3+ in the reaction mixture. Figures 3.3A and B show the
luminescence spectra for Eu- and Tb-doped nanophosphors, respectively. The dopant:Gd
molar concentration ratios in the NaGdF4 synthesis reaction were 0.1% (bottom), 1%,
15%, 20% and 100% (top). A base value has been added to each spectrum to avoid
spectral overlapping. At low and high molar ratios of both Eu and Tb doped
NaGdF4 nanophosphors showed low luminescence intensity due to lack of luminescence
centers and self-quenching (cross-relaxation between two neighboring
Eu3+),38 respectively. Intermediate concentrations, 1%, 15%, and 20% in Eu-doped
NaGdF4 showed the highest although similar luminescence intensities. In Tb-doped
NaGdF4 20% showed the highest intensity.
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Figure 3. 3: X-ray excited optical luminescence (XEOL) of (A) NaGdF4:Eu and (B) NaGdF4:Tb
nanophosphors. Eu and Tb dopant fraction (mol% added to reagents vs. Gd) of NaGdF4
nanophosphors varied from 0.1% to 100%. X-ray luminescence intensities of nanophosphors
were normalized to the 620 nm peak intensity from commercial GOS:Eu and Tb microphosphors.
Spectra have been vertically displaced for ease of comparison. Taken with permission of ref 1.

Hydrothermal synthesis method. The hydrothermal synthesis process is
presented in Figure 3.4A. The crystallinity of inorganic crystals plays an important role in
X-ray luminescence intensity, where a large crystal domain size results in high
luminescence intensity.10 During the hydrothermal process, nanophosphors recrystallize
to rearrange the crystal structure. The nanophosphors synthesized using the co-precipitate
method at room temperature were hydrothermally treated to increase the crystallinity and
enhance the X-ray luminescence intensity. The hydrothermally treated nanophosphors
were irregularly shaped (Figure 3.4B1 and B2) as nanophosphors are starting to
aggregate and fuse at high temperature. However, narrow peaks in the powder XRD
pattern (Figure 3.4B3) confirmed the increased crystallinity compared to nanophosphors
synthesized at room temperature. (∼179 Å NaGdF4:Eu and ∼128 Å NaGdF4:Tb
according to the Scherrer equation based on the peak at 17 degrees).
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Figure 3. 4: (A) Schematic illustration of nanophosphors synthesis according to co-precipitate
method. (i) Mixture of Gd(NO3)3 and Eu(NO3)3 or Tb(NO3)3, (ii) Ln3+–citrate3− complex appears
as a clear solution, (iii) formation of NaGdF4:Ln3+ nanophosphors, (iv) hydrothermally treated
NaGdF4:Ln3+ nanophosphors. TEM images of hydrothermally treated (B1) NaGdF4:Eu and (B2)
NaGdF4:Tb nanophosphors. (B3) Powder XRD pattern compared to PDF cards 27-0699 of
NaGdF4:Eu and NaGdF4:Tb. Taken with permission of ref 1.

TEM images and powder-XRD patterns of 0.1–100% Eu- and Tb-doped

NaGdF4 are included in Figure 3.5.

Figure 3. 5: TEM images of NaGdF4 doped with (i) 0.1%, (ii) 1%, (iii) 15%,(iv) 20%,(v) 100% Eu
synthesized using the hydrothermal method. Scale bar is equal to 100 nm. XRD patterns of (A)
Eu- and (B) Tb-doped NaGdF4 (Gd: dopant molar ratio= 1: 0.1, 1, 15, 20, 100%). XRD data were
collected using single-crystal XRD as an alternative of powder XRD. PDF card is 27-0699. Taken
with permission of ref 1.
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Hydrothermally treated nanophosphors showed enhanced X-ray luminescence
intensity by a factor of 2–2.5 compared to nanophosphors synthesized at room
temperature. 15% Eu doped NaGdF4 showed the highest intensity. However, 1% and
20% Eu doped NaGdF4 showed high values close to the highest intensity ( Figure. 3.6A).
The X-ray luminescence intensity of 15% Tb doped NaGdF4 had the highest intensity,
and 20% Tb doped NaGdF4 showed an intensity close to the highest value (Figure. 3.6B).

Figure 3. 6: XEOL of hydrothermally treated (A) NaGdF4:Eu and (B) NaGdF4:Tb nanophosphor.
Mol fraction of Eu and Tb dopant vs. Gd in regent mixture varied from 0.1% to 100%. X-ray
luminescence intensities of nanophosphors were normalized to the height of 620 nm peak of
commercial GOS:Eu and Tb microparticles. Spectra have been vertically displaced by adding a
baseline for ease of comparison. Taken with permission of ref 1.

3.4.2. Inductive coupled plasma-optical emission spectroscopy (ICP-OES) metal
analysis
ICP-OES analysis was performed for Gd, Eu and Tb to determine the Eu/Gd and
Tb/Gd ratios of the synthesized nanophosphors, which determine X-ray luminescence
intensity. All four types of samples (NaGdF4:Eu and NaGdF4:Tb synthesized by coprecipitate and hydrothermal methods) show an increased percent metal ratio as the
fraction of dopant added increases. The amount of dopant in the final systems was
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directly proportional to amount added to the reagent mix, with a slope of 1.2 for both the
coprecipitated and hydrothermal NaGdF4:Eu (i.e., nanophosphors incorporated 20% more
Eu than was added to the reagent mixture) and 1.3 for the NaGdF4:Tb (i.e.,
nanophosphors incorporated 30% more Eu than was added to the reagent mixture),
suggesting increases in thermodynamic stability or kinetic reaction rates during synthesis.

Figure 3. 7: Metal composition of nanophosphors calculated using ICP-OES measurements. The
graph of percent metal ratio of nanophosphor vs. percent molar fraction of dopant added of
NaGdF4:Eu synthesized by (A1) co-precipitate and (A2) hydrothermal methods and NaGdF4:Tb
synthesized by (B1) co-precipitate and (B2) hydrothermal methods. Note, the amount of Tb in
NaGdF4:0.1%Tb was not calculated as it is lower than the limit of detection of the instrument.
Take with permission of ref 1.

88

3.4.3. Silica-coating NaGdF4:Eu and Tb nanophosphors
NaGdF4:Eu nanophosphors, synthesized at room temperature, were coated with
silica before further experiments. The silica can protect nanophosphors from aggregation
and facilitate functionalization for biological applications. Figure 3.8A presents the
NaGdF4 silica coating process. In electron microscopy images ( Figure 3.8B1) the silica
coating appeared as a ∼15 nm thick shell around the nanophosphors. The average

diameter of NaGdF4:Eu@SiO2 nanophosphors was about 120 nm ( Figure 3.8B2).

Figure 3. 8: (A) Schematic illustration of nanoparticle coating with silica. (i) NaGdF4:Ln3+
nanophosphors, (ii) silica-coated NaGdF4:Ln3+ nanoparticles. (B1) TEM images of silica-coated
NaGdF4 nanophosphors Eu-doped. (B2) Histograms of the diameter of silica-coated
NaGdF4:Ln3+ nanoparticles. (B1) TEM images of silica-coated NaGdF4 nanophosphors Eu-doped.
(B2) Histograms of the diameter of silica-coated NaGdF4:Eu. Take with permission of ref 1.
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Both Tb-doped and Eu-doped nanophosphors showed reduced X-ray
luminescence after coating with silica for the same mass of material. After coating, the
NaGdF4:Eu nanophosphors reduced intensity by ∼42% (Figure 3.9A). This is explained
mainly by the additional silica, which increased the mass by 65% (based on particle
diameter, coating thickness, and density of NaGdF4 core and silica shell) while not
providing any additional luminescent material.

Figure 3. 9: XEOL spectra of silica-coated (A) NaGdF4:Eu and (B) NaGdF4:Tb compared to
NaGdF4:Eu and NaGdF4:Tb synthesized using co-precipitate method. Taken with permission of
ref 1.

3.4.4. Thermal analysis
The stability of the nanophosphors towards heat was studied by thermal gravimetric
analysis (TGA) and differential scanning calorimetry (DSC) thermograms as in Figure
3.10A and B. NaGdF4:Eu and NaGdF4:Tb synthesized using co-precipitate method
showed total weight loss of 12.5% and 12.1% respectively. Their highest weight loss
appeared at 62.5 °C is attributed to the loss of trapped H2O, and weight loss above 250 °C
may cause by the decomposition of citrate. The nanophosphors synthesized using the
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hydrothermal method indicated 3.10% (NaGdF4:Eu) and 5.17% (NaGdF4:Tb) total
weight loss. The vaporization of trapped H2O causes no significant weight loss. Also, the
weight loss above 250 °C is less intense than the weight loss of the co-precipitate
method. Silica coated-NaGdF4:Eu has a total weight loss of 17.4%. Its weight loss at 65.5
°C is attributed to the loss of trapped H2O and ethanol.

Figure 3. 10:(A) TGA and (B) DSC of NaGdF4:Eu and NaGdF4:Tb nanophosphors synthesized
using co-precipitate and hydrothermal methods and NaGdF4:Eu@SiO2. Taken with permission of
ref 1.

The peaks above 250 °C are more intense than for uncoated nanophosphors and likely
caused by decomposition of citrate and PVP organic materials (Figure 3.11B and C).
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Figure 3. 11: TGA thermograms showing (A) weight loss of synthesized nanophosphors, (B)
derivative of weight loss (C) DSC of sodium citrate and PVP. Taken with permission of ref 1.

Further, a DSC thermogram shows that vaporization and decomposition are exothermic
processes. The TGA thermogram shows that nanophosphors synthesized by the
hydrothermal method contain less trapped water and organic materials, which may result
in high X-ray luminescence intensity.

3.4.5. Annealing NaGdF4:Eu nanophosphors
Nanophosphors synthesized using the co-precipitate method and coated with silica have
relatively low luminescence intensity, hindering most in vivo applications such as deep
tissue imaging and implantable biosensors. High-temperature annealing could enhance
luminescence by removing crystal defects, increasing crystal domain size, and removing
trapped water and carbon dioxide.23,24 Unfortunately, when we annealed our
nanophosphors at temperatures above 700 °C, the particles sintered. For example, Figure
3.12 shows that after thermal annealing at 1000 °C, the NaGdF4:Eu nanophosphors
aggregated and fused, making a structure too large for many biological applications.
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However, the luminescence intensity was increased by a factor of ∼7 compared to
nanophosphors synthesized by the co-precipitate method.

Figure 3. 12: (A) SEM image and (B) XEOL of NaGdF4:Eu annealed at 1000 °C for 6 h compared
to NaGdF4:Eu nanophosphors synthesized using co-precipitate and hydrothermal methods.
Taken with permission of ref 1.

Silica coating can act as a protective layer, preventing particles from aggregating
and fusing during the annealing process.24 Annealed nanophosphors at 400 °C (Figure
3.13A) showed separate particles with a thin silica coating. Annealing at 600 °C ( Figure
3.13B) showed single and separate nanophosphors with a silica shell and nanophosphor
core, but the core had compressed, and some void space was apparent. Annealing at 1000
°C ( Figure 3.13C) caused the nanophosphors to aggregate, although not to the extent of
forming the large porous structures observed without coating (Figure 3.12A).
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Figure 3. 13: TEM images of NaGdF4:Eu@SiO2 nanophosphors annealed at (A) 400 °C, (B) 600
°C (C) 1000 °C. Taken with permission of ref 1.

Annealing at 400 °C and 1000 °C increased the luminescence intensity by a factor
of ∼1.5 and ∼3 compared to unannealed silica-coated nanophosphors. Among the three
annealing temperatures, 1000 °C showed the highest intensity ( Figure 3.14A).

Figure 3. 14: (A) XEOL of NaGdF4:Eu@SiO2 annealed at 400 °C, 600 °C and 1000 °C for 6 h.
(B) Powder XRD pattern of annealed NaGdF4:Eu@SiO2 at 600 °C and 1000 °C compared to PDF
cards 00-056-0184 and 00-027-0699 biotin functionalized NaGdF4:Eu@SiO2. Taken with
permission of ref 1.

We also observed that the XEOL spectrum red-shifted at high temperatures (600 °C and
1000 °C). This spectral shift could potentially be useful for generating nanophosphors
with distinguishable spectra for multi-modal imaging and likely arises from changes in
composition and crystal field. A potential future direction with spectrally distinguish
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NaGdF4:Eu and Gd2O2S: Eu is explained in chapter 6. (XEOL graphs of synthesized,
annealed, and silica-coated NPs are included in Figure 3.15 to compare).

Figure 3. 15: X-ray excited optical luminescence (XEOL) spectra of bare synthesized, silica coated,
and silica coated annealed Eu-doped NaGdF4 NPs. Taken with permission of ref 1.

Indeed, powder-XRD data confirmed the formation of sodium gadolinium silicate
compound by reacting with the silica layer: XRD spectra display the presence of
NaGd9Si6O26:Eu (Figure 3.14B) indexed to the standard data (JCPDS 00-056-0184).
Additionally, we observed that the 1000 °C annealed samples have sharper diffraction
peaks indicating larger crystal domains, likely reducing quenching from the surface and
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defects.10 Also, at 1000 °C, the nanophosphors have started to aggregate. On balance, the
1000 °C annealing appeared to give the best performance, albeit with a spectral shift.
XEOL graphs of NaGdF4:15%Eu annealed at 150, 400, and 1000 °C for 12 h are
included in Figure 3.16.

Figure 3. 16: XEOL spectra of NaGdF4:Eu@SiO2 unannealed and annealed at 150, 400, and 1000 °C
for 12 hours. Taken with permission of ref 1.

3.4.6. Biotin functionalized NaGdF4:Eu@SiO2
Functionalizing rare-earth-doped nanophosphors is important in vivo labeling and
imaging, biological assays, and sensor applications with specific targets such as proteins
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and DNA.12,40,41 We functionalized NaGdF4:Eu@SiO2 nanophosphors (not annealed)
with a mixture of PEG-phosphate and biotin-PEG. The PEG-phosphate was chosen to
have good dispersion of surface-modified nanophosphors in water at physiological pH
and high ionic strength (PBS buffer). The biotin-functionalization was demonstrated by
attachment to streptavidin-functionalized buoyant silica microbubbles (Figure 3.17).

Figure 3. 17: Schematic illustration of (A) silica coated nanophosphors functionalized with biotin
(i) silica-coated NaGdF4:Eu nanophosphors, (ii) amine-functionalized nanophosphors, (iii) biotinfunctionalized nanophosphors. Biotin is connected to amine-functionalized
nanophosphors via sulfo-NHS groups, (B) biotin functionalized nanophosphors attach to
streptavidin coated silica microbubbles. (i) streptavidin-coated silica microbubbles, (ii) biotinfunctionalized nanophosphors attached to streptavidin-coated silica microbubbles. (C) SEM
image showing biotin-functionalized nanophosphors attached to streptavidin-coated
microbubbles. Taken with permission of ref 1.

3.4.7. X-ray excited optical luminescence spectroscopy and imaging of
capillaries filled with NaGdF4:Eu through tissue
XEOL spectroscopy and imaging were performed to demonstrate the ability to
excite the nanophosphors through tissue and show that the luminescence could be
generated in specific regions using a focused X-ray source. We chose 5 mm of chicken
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breast because 5 mm is sufficient for many applications in a mouse model where the
“radius” is <1 cm, and we used chicken breast because it is a common tissue material that
scatters light. Optical scattering in chicken breast is highly anisotropic and has larger
transport mean free path (the length over which the direction of photon propagation is
randomized) than scattering mean free path.42
XEOL spectroscopy of colloidal NaGdF4:Eu nanophosphors in capillaries was
measured with and without being sandwiched between two 4 mm porcine tissue. Figures
3.18A1 and B1 show a schematic illustration of the experimental setup. The glass slide
carrying capillaries (1 mm diameter) filled with a nanoparticle solution (0, 50, 100 mg
mL−1) is placed on the microscope stage. The light generated in X-ray irradiated
nanophosphors was collected through a microscope lens and sent to a spectrograph.
Spectra generated without tissue (Figure 3.18A2) shows intensity higher than capillaries
sandwiched between porcine tissues (Figure 3.18B2). Also, as the concentration of
nanophosphors increases, the capillary intensity increases in both scenarios.
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Figure 3. 18: Schematic illustration of measuring XEOL of NaGdF4:Eu filled in capillaries (A1)
without tissue (B1) sandwiched with two 5 mm porcine tissues. XEOL of NaGdF4:Eu filled in
capillaries (A2) without tissue (B2) sandwiched with two 5 mm porcine tissues. Exposure time was
10 s without tissue and 60 s through tissue. Taken with permission of ref 1.

To demonstrate focused X-ray excited light generation and collection through
tissue, we loaded 1 mm diameter glass capillaries with NaGdF4:Eu nanophosphor
dispersions and placed the capillaries beneath 5 mm porcine tissue for imaging (Figure
3.19). Three capillaries were used, with NaGdF4 concentrations of 0, 50, and 100 mg
mL−1, respectively. Our 0.75′′ diameter collection optics and coupled acrylic light guide
collected light from a large field of view (∼1′′), but the focused X-ray beam irradiated
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only a small region (∼250 μm spot size). We found a relatively sharp image showing
luminescence only from the filled region of the capillaries and excellent agreement with
the X-ray transmission image.

Figure 3. 19: XELCI images of NaGdF4:Eu dispersion in capillaries (A) XELCI images without
tissue (i) image of 620 nm intensity (counts) vs. position. (ii) Image of 700 nm intensity (counts) vs.
position (iii) XELCI ratio image (intensity ratio of 620 nm and 700 nm). (B) XELCI images of the
same capillaries sandwiched between two 5 mm porcine tissue slices (i) 620 nm image (ii) 700 nm
image (iii) XELCI ratio image. (iv) Superimposed 620 nm image and X-ray transmittance images.
Current was 200 μA without tissue and 600 μA through tissue. 1 mm scale bar is same for all
images. Taken with permission of ref 1.

The capillary with DI water (0 mg mL−1) produced dim luminescence, as glass
displays a weak X-ray luminescence signal43 with a broad spectrum roughly peaking at
430 nm (Figure 3.20).
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Figure 3. 20: Full-scale XEOL of NaGdF4: Eu in capillaries A) without tissue B) sandwiched
between 5 mm slices of porcine tissue. Taken with permission of ref 1.

The signal at 50 mg mL−1 and 100 mg mL−1 are much larger and increase
proportionally to concentration. Importantly, although the signal through tissue was 9.6
times weaker than with no tissue (mainly due to optical attenuation and partly from X-ray
attenuation), the observed spatial resolution was very similar, demonstrating local
radioluminescence excitation through tissue.

3.4.8. MR imaging of NaGdF4:Eu and Tb
NaGdF4:Eu and Tb may also potentially be T1 and T2 weighted MRI contrast
agents as previously reported.44,45 To demonstrate this, varying concentrations of
NaGdF4:Eu and Tb were prepared in DI water and imaged using a 3T Siemens
MAGNATOM Prisma MRI (Figure 3.21A and B). As expected, T1 weighted images
became brighter, and T2 weighted images became darker as [Gd] increased up to 0.4
mM. Figure 3.21C and D show longitudinal and transverse 1H relaxation
rates, r1 and r2, measured at 20 °C plotted against concentration of the nanoparticle
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suspensions. Relaxivities were calculated by linear regression of this data. The
longitudinal relaxivities for NaGdF4:Eu and NaGdF4:Tb were 4.0 ± 0.15 and 2.7 ± 0.16
mM−1 s−1, and the transverse relaxivities were 58 ± 1.0 and 110 ± 10 mM−1 s−1,
respectively. The observed differences between Tb and Eu doped particles, especially at
high concentrations, are likely from variation in sample preparation since Tb and Eu
doping is at a low concentration compared to the Gd in the host crystal. The values are in
the range of prior literature, and the relaxivities provide clear contrast.44 The reported
relaxivity values 0.27 (minimum r1) and 160 (maximum r2) mM−1 s−1 depends on field
strength,44,46 size and morphology44,46 and coating.47 MRI imaging would allow for deep
tissue imaging and would be complementary to X-ray luminescence imaging and
stimulation, allowing for non-invasive localization of nanophosphors in vivo.

Figure 3. 21: Magnetic resonance images (MRI) of NaGdF4:Eu and NaGdF4:Tb nanoparticle
suspensions in water. (A) T1 weighted and (B) T2 weighted images with various nanoparticle
concentrations. 0 mM = DI water. 1 cm scale bar is for both T1 and T2 weighted images. (C)
Longitudinal relaxation rate vs. concentration for nanoparticle suspensions. (D) Transverse relaxation
rate vs. concentration. Dashed lines are linear fits to data. Taken with permission of ref 1.

102

3.5. Conclusions
We described two methods to synthesize Eu- and Tb doped NaGdF4 X-ray luminescence
nanophosphors. The co-precipitation method is a simple method that synthesizes
spherical-shaped nanoparticles at room temperature. The hydrothermal method generated
irregular particles that yielded higher X-ray excited luminescence intensity. Our
investigation of annealing nanoparticles revealed that nanoparticles without a silica
coating resulted in high luminescence intensity yet aggregated particles. The silica
coating act as a protection layer to prevent aggregation and increase X-ray luminescence
during the annealing process. However, at high temperature, it transformed NaGdF4:Eu
into sodium gadolinium silicate, which also shows X-ray luminescence. Then, we
functionalized NaGdF4:Eu@SiO2 nanophosphors with biotin and confirmed attaching to
streptavidin in vitro. Importantly, we selectively excited scintillator nanophosphors using
a focused X-ray source to generate light and collect them through the tissue to generate
XELCI images and XEOL was measured through tissue. We also showed that the
particles could serve as MRI contrast agents. Future work will investigate the spectral
shift by changing host materials for multi-analyte imaging through tissue.
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CHAPTER FOUR
FUNCTIONALIZING RADIODENSE PARTICLES AND DEVELOPING
IMMUNOASSAYS TO DETECT SARS-CoV-2 ANTIBODIES

4.1. Abstract
As discussed in chapters one, two, and three, plasmonic and X-ray luminescence
nanoparticles have interesting optical properties depending on their size, shape, crystal
structure, etc. Another important property of these nanoparticles is their surface area
which can be functionalized with biomolecules and target specific biomolecules and
components to detect and quantify them. Therefore, these nanoparticles are used in
developing biosensors/ immunosensors. In this chapter, plasmonic and X-ray
luminescence nanoparticles were used to develop two immunoassays (a lateral flow assay
and an implantable immunoassay).
Lateral flow assays are the most common point-of-care device available to
confirm the presence or absence of an analyte. Many LFAs are available to detect
COVID -19 antibodies (human anti-spike IgG and IgM) in human blood or serum.
However, there is no available LFA to detect COVID- 19 antibodies (human anti-spike
IgG and IgA) in human saliva. Therefore, we are developing a lateral flow assay (LFA)
to detect SARS-CoV-2 antibodies in human saliva. Our preliminary studies show the
proof of concept of the designed LFA. Further, we have demonstrated the proof of
concept of an immunoassay using RBD functionalized AuNPs, and anti-spike IgG
functionalized x-ray luminescence microparticles (Gadolinium oxysulfide). When AuNPs
are attached to Gadolinium oxysulfide microparticles, the x-ray luminescence is
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decreased. This approach can be used to develop an implantable immune assay that can
quantify biomarkers in vivo locally and continuously.

4.2. Introduction
This chapter describes the development of two immunosensors that use light
scattering and absorption properties of gold nanoparticles and X-ray excited optical
luminescence of X-ray scintillators. As discussed in chapter one, the surface of a
nanoparticle can be functionalized with biomolecules such as proteins (antibodies,
antigens, enzymes, etc.) and nucleotides (single-strand DNA, RNA) for in vivo imaging
and diagnostics1. By functionalizing nanoparticles with antibodies, it can target and
specifically binds to antigens. The optical properties of the functionalized particles are
used to detect and quantify the specific antigens. The size of gold nanoparticles and Xray luminescence microparticles we used in this section is ~20 nm and 2.5 µm,
respectively. The typical length of an antibody is 10 nm.2 The biomolecule functionalized
gold nanoparticles, and X-ray luminescence microparticles are used to detect SARSCoV-2 antibodies.
Coronavirus disease 2019 (COVID-19) is the current outbreak of coronavirus
caused by the SARS-CoV-2 virus, and it is still playing a vital role around the world. By
January 2022, more than 300 million confirmed cases, 5 million related deaths1a, and 12
virus variants1b have been reported worldwide. There are several FDA-approved
vaccines1c and public health strategies (social distancing and wearing masks) to slow
down and control the pandemic. However, reopening businesses and easing restrictions
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on human mobility and interactions will depend on accurate estimates of population-level
infection and markers of immunity4,5.
RT-qPCR and the rapid antigen test (RAT) are the most common diagnostic tests
for COVID-19. However, both these tests can diagnose current infections only. It cannot
diagnose most recent or previous COVID-19 infections. Therefore, to identify past
infection, confirm vaccine trials are working, and make sure a specific community is at
herd-immunity level, SARS-CoV-2 antibody detection assays are required.
Enzyme-linked immunosorbent assay (ELISA) and Lateral flow assay (LFA) are
the common immunoassays available for detecting SARS-CoV-2 antibodies. ELISA is a
laboratory-based quantitative method that is expensive and time-consuming. On the other
hand, LFAs are point-of-care assays and produce qualitative results in minutes. In April
2020, Food and Drug Administration (FDA) approved the 1st serological LFA
(https://www.fda.gov/media/136625/download). So far, there are several EUA authorized
LFAs available in the market to test antibodies in blood and serum6. However, there are
limitations associated with current LFAs. Most of these test kits give high specificity and
sensitivity in clinical trials. Still, real-world performance is uncertain, giving falsepositive results due to cross-neutralization between SARS-CoV and SARS-CoV-27, less
accurate in early stages of infection and IgM and IgG combined assay shows better
performance.
This chapter will discuss developing an LFA to detect SARS-CoV-2 antibodies
(IgG and IgA) in human saliva and an implantable immunoassay to detect SARS-CoV-2
antibodies (IgG) in blood/serum. Even though many LFAs detect COVID-19 antibodies
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in blood and serum, there are no available LFAs to detect antibodies in saliva. The
previous COVID-19 antibody tests (IgG and IgA) done using ELISA have shown 84.0%
sensitivity and 90.6% specificity with whole saliva samples collected from the general
symptomatic population. Sensitivity was improved by pelleting mucus and treating saliva
with TBS-Tween and 5% BSA. However, it comes at a cost to the specificity8. The
optimum data were collected by removing mucus, concentrating the samples, and
blocking non-specific binding, giving 84.2% sensitivity and 100% specificity. These
values can go up to 100% sensitivity and specificity in serum.
Here we describe the implantable immunoassay to detect SARS-CoV-2 antibodies
(IgG). However, this is only a proof of concept to show that x-ray luminescence
nanoparticles can be used to develop implantable immunoassays that can measure
biomarkers in deep tissues, synovial fluid, and cerebrospinal fluid locally and
continuously in the future.

4.3. Methods
4.3.1. Designing and developing an LFA to detect SARS-CoV-2 antibodies (Proof
of concept)
Universal lateral flow assay kits (ab270537) were purchased from Abcam, USA.
The assay kit protocol was used to develop the proof-of-concept sandwich lateral flow
immunoassays to detect SARS-CoV-2 antibodies with slight modifications9.
α-human IgG and IgA antibody conjugated ulfa-tag. α-human IgG and IgA
(1mg/mL, 10 µL) were separately mixed with the modifier reagent (1 µL) given in the

116

test kit. The above mixtures were added to given ulfa-tag vials and resuspended gently by
pipetting. The two vials were kept at room temperature overnight. LL-quencher (1 µL)
was added to the ulfa-tag vials and held 30 minutes before use.
Spike proteins (RBD and trimeric) functionalized AuNPs. RBD and spike
proteins (1 mg/mL) were diluted to 0.1 mg/mL using provided gold-antibody-diluent.
Spike proteins (12 µL) were added to the reaction buffer (42 µL) and 45 µL of this
mixture was added to vials containing freeze-dried AuNPs (40 nm). The reaction was
kept 15 minutes at room temperature before adding the gold quencher (5 µL). Then, spike
proteins conjugated AuNPs were washed with 10 times diluted gold-antibody-diluent and
stored in the same solution containing 0.5% BSA. The final solutions contain spike
proteins conjugated AuNPs (OD=20, 50 µL).
LFA test procedure. Universal running buffer (10x) was diluted to 1x using DI
water, and the final buffer solution contains 0.1% BSA. Ulfa-Tag conjugated α-human
IgG and Ulfa-Tag conjugated α-human IgA were diluted (1x) to prepare 50 mg/mL
solutions, and gold-spike protein conjugates were diluted to obtain 6 OD using the
universal running buffer.
Gold-biotin (40 nm, OD= 10) was diluted to 1 OD using universal running buffer
to use in the control line. The analyte (human anti-spike IgG) was diluted to prepare 10
and 100 ng/mL solutions using universal running buffer. Each test was duplicated, and
for a single strip, diluted capture Ulfa-tag-conjugated α-human IgG or IgA (5 µL), gold
spike protein conjugate (5 µL), gold-biotin conjugate (5 µL) and human anti-spike IgG
(75 µL) were added to each well of low protein binding 96-well plate and incubated at
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room temperature for 30 minutes. Test stripes were added and read after 20 minutes.
Negative control was run without analyte (human anti-spike IgG), just adding running
buffer (75 µL).
4.3.2. Functionalizing gold NPs with SARS-CoV-2 receptor-binding domain
(RBD) protein
Gold nanoparticles (AuNPs, 20 nm spheres) were purchased from
Cytodiagnostics Inc, Canada. The AuNPs were first coated with polyethylene glycol
(PEG) and then functionalized with RBD protein using EDC/ Sulfo-NHS coupling.
PEG-coated AuNPs. Thiol-PEG-carboxylic (SH-PEG5k-COOH, 60 mg/mL, 1
mL) and thiol-methyl PEG (SH-mPEG5k, 60 mg/mL, 100 µL) were prepared in 50%
ETOH and transferred to a round bottom flask which contains 50 mL of DI water. The
mixture was stirred for 15 minutes before adding AuNPs (10 OD, 500 µL). After adding
AuNPs, the reaction mixture was continued to stir for another 15 minutes before keeping
at 4 °C overnight. Then, the PEG-coated AuNPs (Au@PEG) were washed three times
and collected by centrifuging at 5000g (RCF) for ½ hour. Au@PEG were dispersed in DI
water (10 mL) and kept at 4 °C.
SARS-CoV-2 RBD protein functionalized AuNPs. Au@PEG (four portions of
1 mL) was centrifuged and collected. Au@PEG were redispersed in three different
buffers at 5.0 mM, 5.0 pH (HEPES, MOPS, and MES), and DI water (pH~ 6.5). Then
EDC ((1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride), 1 mg/mL, 25
µL) and Sulfo-NHS (N-hydroxysulfosuccinimide, 1 mg/mL, 40 uL) were added and it
was reacted for 40 minutes. Nanoparticles were washed and collected by centrifuging,
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and RBD protein (50 µg/mL) in 1.0 mL HEPES buffer (10 mM, pH= 7.4) were added to
the EDC/Sulfo-NHS treated Au@PEG nanoparticles. It was reacted for 2 hours at room
temperature before keeping at 4 °C overnight. The RBD protein functionalized AuNPs
(Au@PEG:RBD) were collected by centrifuging at 5000g for ½ hour. Then,
Au@PEG:RBD were redispersed in 10.0 mM, 7.4 pH HEPES containing 1.0 mM
ethanolamine and 0.1% BSA and kept at room temperature 5 minutes. Finally,
Au@PEG:RBD were washed, collected and redispersed in 10.0 mM HEPES containing
0.1% BSA.
Uv-vis extinction spectra of AuNPs, Au@PEG, and Au@PEG:RBD were
collected using a Uv-vis spectrophotometer (Shimadzu corp., Uv 3600 plus, Uv-Vis-NIR
spectrophotometer).
4.3.3. Functionalizing Eu doped gadolinium oxysulfide (Gd2O2S:Eu/ GOS:Eu, 2.5
µm) microparticles with human anti-spike IgG antibodies
PEG-coated GOS:Eu microparticles. Silane-PEG-carboxylic (SiO2-PEG5kCOOH, 60 mg/mL, 1 mL) and Silane-methyl PEG (SiO2-mPEG5k, 60 mg/mL, 100 µL)
were prepared in 90% ETOH and transferred to a Teflon tube which contains 10.0 mL of
90 %ETOH. The mixture was mixed using a rotator for 15 minutes before adding
GOS:Eu microparticles (20 mg) dispersed in 1 mL 90% ETOH. After adding GOS:Eu
microparticles, the reaction mixture continued to rotate for another 30 minutes before
keeping at 4 °C overnight. Then, the PEG-coated AuNPs (GOS:Eu@PEG) were washed
three times and collected by centrifuging at 500g (RCF) for 5 minutes. GOS:Eu@PEG
were dispersed in DI water (2 mL) and kept at 4 °C.
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Human anti-spike IgG antibodies functionalized AuNPs. GOS:Eu@PEG (1
mL) was centrifuged and collected. GOS:Eu@PEG were redispersed in HEPES buffers
(5.0 mM, 5.0 pH). Then EDC (100 µL, 1 mg/mL) and Sulfo-NHS (150 µL, 1 mg/mL)
were added, and it was reacted for 40 minutes. Microparticles were washed and collected
by centrifuging, and Human anti-spike IgG antibodies (75 µg/mL) in 1 mL HEPES buffer
(10 mM, pH= 7.4) were added to the EDC/Sulfo-NHS treated GOS:Eu@PEG
nanoparticles. It was reacted for 2 hours at room temperature before keeping at 4 °C
overnight. The Human anti-spike IgG antibodies functionalized GOS:Eu microparticles
(GOS:Eu@PEG:IgG) were collected by centrifuging at 500g for 5 minutes. Then,
GOS:Eu@PEG:IgG were redispersed in 10.0 mM, 7.4 pH HEPES containing 1.0 mM
ethanolamine and 0.1% BSA and kept at room temperature 5 minutes. Finally,
GOS:Eu@PEG:IgG were washed, collected and redispersed in 10 mM HEPES
containing 0.1% BSA.
To attach AuNPs onto GOS:Eu microparticles, 200 µL of Au@PEG:RBD in
HEPES were added to GOS:Eu@PEG:IgG in HEPES (200 µL), and the mixture was
inverted a couple of times to mix. Photographic images were taken under UV light (395
nm). Transmission electron microscope images were taken from Hitachi HT7800
operating at 20–120 keV and 8 μA. PEG coated AuNPs and GOS:Eu@PEG:IgG were
mixed to obtain negative control.
4.3.4. ray excited optical luminescence (XEOL) spectroscopy
X-ray luminescence of control and sample were measured by irradiating with an
X-ray beam. 200 uL of both samples were placed on the stage of an inverted microscope
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and irradiated with an X-ray beam generated using a Mini-X (Ag) X-ray source (Amptek,
Bedford, MA) set at 40 kV and 99 μA. The emission of nanoparticles was collected by 5x
objective and focused on a spectrograph (DNS 300, DeltaNu, Laramie, WY, USA),
equipped with a cooled CCD camera (iDUS-420BV, Andor, South Windsor, CT, United
States) with 30 s exposure time.
4.4. Results and Discussion
4.4.1. Designing and developing an LFA to detect SARS-CoV-2 antibodies (Proof
of concept)
The LFA to detect SARS-CoV-2 antibodies in human saliva was designed by
considering the current availability and needs in the market. The currently available
LFAs to detect SARS-CoV-2 antibodies use serum or blood, and draining blood is
painful for the patient, and separating serum from blood is required. Therefore, using
saliva is simple and easy. IgA is mainly found in mucus, and the IgG amount in saliva/
mucus is correlated with the serum IgG in serum10. Furthermore, the previous studies
using ELISA show the ability to use IgG, IgA, and IgM to detect SARS-CoV-2
antibodies in serum11 and saliva8,12. By considering these factors, the designed LFA is
illustrated in figure 4.1.
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Figure 4. 1: Design of new lateral flow assay to test anti-spike IgG and IgA in human saliva.

After designing the LFA, proof of concept experiments was carried out using a
universal LFA kit. Figures 4.2A and B show the experimental steps and results. 1st RBD
or trimeric conjugated AuNPs and anti-human IgG or IgA conjugated Ulfa tags were
prepared. Next, they were mixed with human anti-spike IgG antibodies to form an
antibody-antigen complex. Then, the test strip was dipped in the solution, which contains
the above complex and biotin-conjugated AuNPs. Ulfa tag binds with the anti-ulfa tag on
the test line, and if the Ulfa tag contains the antibody-antigen complex, the test tine
shows up in red color. The control line has streptavidin biotinylated AuNPs bound to it
and shows red color. According to the results, both RBD and trimeric showed positive
results for anti-spike IgG. However, we could not test for anti-spike IgA instead of antispike IgG on IgA conjugated Ulfa tag. The result was negative and confirmed there’s no
is no cross-reaction between the anti-spike IgA and anti-human IgG.
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Figure 4. 2: Schematic illustration of (i) preparing RBD conjugated AuNPs and anti-human IgG
conjugated Ulfa tag, (ii) combining RBD conjugated AuNPs, human IgG conjugated Ulfa tag, and
biotin-conjugated AuNPs, (iii) dipping the LFA test strip. Images of LFA test strip. Images of
LFA test strips after running (B) human anti-spike IgG and (C) human anti-spike IgA.

AuNPs were coated with PEG (SH-PEG5k-COOH and SH-mPEG5k) using
previously described methods with slight modifications13,14. According to Ron et al., thiol
may react with the oxidative gold surface via an oxidation-reduction reaction. AuNPs
surface is reduced, and thiol adsorbs onto Au surface followed by chemisorption, which
includes breaking the S-H bond and forming Au-S bond. Breaking of S-H bond is
favorable in slightly basic media; however, to the best of our knowledge, the effect of pH
is not yet well studied15. Then the RBD proteins were covalently bound to the carboxylic
acid group using EDC/Sulfo-NHS coupling. The optimum reaction condition for most
EDC/Sulfo-NHS reactions is acidic (pH ~4.5-6.0)16,17. However, some protocols are
optimized to work in neutral and slightly basic media (pH ~4.5-7.2)18,19. In this
experiment, 5.0 pH was selected considering pKa of most carboxylic acid groups (~4-5
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e.g., pKa value of acetic acid =4.74 and butanoic acid=4.8220), the stability of Au@PEG
in the medium. After EDC/Sulfo-NHS coupling, AuNPs were washed, and the pH value
was brought to 7.4 by adding HEPES (10 mM). As the isoelectric point of RBD (pI=
7.36–9.85, spike protein pI= 5.9,6.24)21 and human anti-spike IgG (pI= 6.6-7.2)22,23 are
around at neutral pH, the bioconjugation was done at 7.4. However, the pI of SARS-CoV2 proteins was estimated using computational methods, and the actual values may be
lower than the calculated values24.
4.4.2. Functionalizing gold NPs with SARS-CoV-2 receptor-binding domain
(RBD) protein
Using UV-Vis spectroscopy, the PEGylation of AuNPs and protein binding to
carboxylic acid were monitored (Figure 4.3). The wavelength that gives the maximum
extinction (λmax) of AuNPs is 520 nm, and upon addition of PEG coating λmax value is
shifted to the red side and shows up at 523 nm. This value is consistent with the previous
studies done with 10-50 nm AuNPs coated with PEG (5 and 6 kDa)25,26. When protein is
attached to the carboxylic acid group λmax value further shifts to red (526 nm), showing
an increase in size. Absorption peaks of peptide bonds and free proteins were observed at
210 and 280 nm, respectively27,28.
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Figure 4. 3: (A) Schematic illustration of functionalizing route of RBD functionalized AuNPs. (B)
UV-Vis spectra showing λmax of bare AuNPs, Au@PEG, Au@PEG:RBD and RBD protein in
different buffer solutions.
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4.4.3. Developing an x-ray luminescence immunoassay to detect SARS-CoV-2
antibodies (Proof of concept)
Our previous studies with 50 nm GOS:Eu show around 90% reduction in x-ray
luminescence intensity when attaching to 30 nm AuNPs. The positively charged PEGNH3+ functionalized AuNPs were attached to GOS:Eu by adsorption (electrostatic
interaction)29. Our current study showed that RBD functionalized AuNPS binding to antispike IgG functionalized GOS:Eu microparticles via antibody-antigen interaction.
GOS:Eu were excited under UV light and imaged the light reduction in figure 4.4B. The
sample clearly shows the decrease of emitted light compared to the control, containing
PEG-coated AuNPs and GOS:Eu microparticles. Further, this observation was confirmed
by X-ray excited optical luminescence spectra. The light reduction of AuNPs attached
GOS:Eu microparticles is a factor of 1.81 compared to control (Figure 4.4D). With these
results, we will be able to develop this immunoassay to detect and quantify biomarkers in
vivo locally and continuously. The future direction is to use a GOS:Eu microparticles or a
thin film and gold nanoparticles functionalized with biomolecules (e.g., antibodies) and
covered with a semipermeable membrane. The molecules of interest (e.g., antigen) can
pass through the membrane and make an antibody-antigen complex, resulting in low Xray luminescence intensity. As the control region, unfunctionalized microparticles or a
thin film and gold nanoparticles without functionalizing. In overall design includes two
areas, the control region which use as the spectral reference and the sample region.
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Figure 4. 4: (A) Schematic illustration of RBD functionalized AuNPs binding to anti-spike IgG
GOS:Eu microparticles. (B) Image showing control and the sample under UV light irradiation.
(C) TEM image of RBD functionalized AuNPs bound to anti-spike IgG GOS:Eu microparticles.
(D) X-ray excited optical luminescence of control and the sample.

4.5. Conclusions
Here, plasmonic and X-ray luminescence nanoparticles were used to develop two
immunoassays (a lateral flow assay and an implantable immunoassay). The visible light
scattering and absorption of gold nanoparticles and X-ray luminescence emitted by X-ray
scintillators (GOS:Eu) are used to detect SARS-CoV-2 antibodies. To target the SARSCoV-2 antibodies specifically, gold nanoparticles were functionalized with antigens. In
summary, AuNPs were coated using PEG and functionalized with SARS-CoV-2 spike
proteins using EDC/ Sulfo NHS coupling. Also, we have functionalized GOS:Eu
microparticles with anti-spike antibodies using a similar approach. Using these particles,
we have shown the capability of developing an x-ray luminescence immunoassay to
detect SARS-CoV-2 antibodies. The significance of this proof of concept is it can be
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developed as an implantable immunoassay in the future. Further, the designed LFA can
also be developed as commercial LFA to detect SARS-CoV-2 antibodies.
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CHAPTER FIVE
X-RAY STIMULATED EGG EJECTION OF C. ELEGANS
The material in this chapter was published as a pre-print article and submitted for peerreviewed publication: Cannon, K. E.; Ranasinghe, M.; Do, A.; Pierce, H. M.; Millhouse,
P. W.; Roychowdhury, A.; Foulger, S.; Dobrunz, L.; Anker, J. N.; Bolding, M. LITE-1
Dependent X-Ray Sensitivity in C. elegans. bioRxiv 2019, 766568.
https://doi.org/10.1101/766568.
The experiments in the paper were initiated and carried out with the collaboration of the
University of Alabama at Birmingham (Kelli Cannon, Dr. Mark Bolding). This chapter
includes only the experiments conducted alone by the author.
5.1. Abstract
In the previous chapters, the dissertation discussed on optical properties of
plasmonic and X-ray luminescence nanoparticles and functionalizing them to develop
immunosensors. This chapter focuses on a somewhat different concept related to
optogenetics, which uses visible light to stimulate genetically modified neurons and
control animal behavior. Specifically, this chapter discusses the discovery of X-rayinduced behavior of C. elegans, like X-ray luminescence nanoparticles use X-ray to
produce visible light, X-ray is used to stimulate the LITE-1 photoreceptor of C. elegans.
Many research groups explore alternative light sources to use in optogenetics.
Several research groups are researching to use of visible light generated from X-ray
luminescence nanoparticles to stimulate neurons. One of the main objectives of
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synthesizing bright X-ray luminescence nanoparticles (described in chapter 3) is to use
them in neuron stimulating studies in C. elegans. The initial concept is to synthesize and
functionalize X-ray nanoparticles to attach to genetically modified C. elegans neurons
and control their behavior with the visible light exposed to X-ray. However, When the
control study was performed, we observed that C. elegans (wild-type) avoid X-ray beams
(without nanophosphors). Here, we describe a study that monitors C. elegans behavior
when exposed to X-rays. In the study, two strains of C. elegans (wild type N2, transgenic
Pmyo-3::lite-1) were exposed to an X-ray beam with 0 (no X-ray) and 1 Gy/s radiation
doses to study their locomotory and ovulation behavior, respectively. At 1 Gy/s radiation
dose, wild-type N2 moved away from the X-ray beam spot with increased locomotory
movement. Pmyo-3::lite-1, which was transgenically expressed LITE-1 photoreceptor in
X-ray insensitive body wall muscles, showed ovulation when exposed to X-ray. These
findings may be vital for understanding the mechanism of LITE-1 signaling, how
organisms respond to radiation, and, more importantly, developing optogenetics tools to
stimulate transgenically modified neurons in deep tissue using X-rays.

5.2. Introduction
In previous chapters (1-4), the optical properties of plasmonic and X-ray
luminescence nanoparticles were discussed. Chapter two studied light scattering due to
LSPR of plasmonic nanoparticles by developing a mechanical approach to preparing the
size/ shape tuning of localized surface plasmon resonance and spatial patterns. Like
chapter two, chapter three discussed several methods to enhance the X-ray excited optical
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luminescence intensity of X-ray luminescence nanoparticles and used in high-resolution
imaging through tissue. In chapter four, both types of particles were brought together to
develop two immunosensors that use the advantage of surface area to functionalize with
biomolecules and optical properties to detect biomarkers. This chapter discusses a
different concept but related to X-ray sensing and change in animal (C. elegans) behavior
due to X-ray stimulation. C. elegans are widely used in optogenetic studies, and also,
they are sensitive to light (UV, blue light) even without optogenetic manipulations. Like
in chapters three and four, here, an X-ray is used; however, it is used to stimulate neurons
in this scenario. Also, recently scientists have been researching to use X-ray
luminescence nanoparticles in optogenetic studies as a light source to stimulate neurons.
This is discussed further in the next paragraph. However, this chapter includes a research
project that was carried out to discover the X-ray stimulated behavior of C. elegans.
Optogenetics uses light to activate light-sensitive photoreceptors (opsins) located
in the plasma membrane of neurons that permit spatial and temporal control of neuronal
activities1. Since its discovery in 2005, optogenetics has become a vital tool that has led
to many discoveries (E.g., identifying the connection between dopamine behavior related
to pain and fear2, treating chronic pain3) and has been extensively developed and adapted.
However, there are many limitations associated with the light source. The most common
light sources used in optogenetics are fiber optics, implantable light sources (LED light),
and carnival windows are used to guide light through the skull4. Therefore, applying
optogenetics has many limitations, such as invasive, limited fields of view, and light
scattering and absorption through tissue.
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Consequently, researchers worldwide are investigating alternative light sources
such as near-infrared (NIR), X-ray, and injectable light sources (radioluminescence
nanoparticles). Recently, several groups have been exploring a technique called X-ray
optogenetics (x-genetics)5–7, which uses radioluminescence particles (RLPs) to inject and
locate close to the neurons. These particles can generate visible range light by X-ray
attenuation and activate transgenically expressed photoreceptors. However, the major
limitation here is to produce enough light to activate neurons. Therefore, we are
investigating highly sensitive photoreceptors (E.g., G-protein coupled receptors) that can
overcome the activation barrier using fewer photos. We came across LITE-1, an unusual
UV-sensitive G-protein coupled receptors (GPCR) photoreceptor protein found in C.
elegans that has been shown to absorb photons orders of magnitude more efficiently than
several common opsins8.
C. elegans is a tiny, free-living, transparent nematode (roundworm) that lives in a
soil environment. The length of an adult worm is about 1-1.5mm. They are easy to grow
on a petri dish seeded with Escherichia coli as the food source. Also, they are fastgrowing animals with a short life cycle (3 days). It is difficult to see them with the naked
eye because of their small size (~1 mm) and transparency. However, we can use
dissecting microscopes to visualize their movements, eating habits, developments, and
laying eggs; confocal microscopes can be used to see cell development and function at a
single-cell resolution. Further, proteins and other cell components can be visualized by
fluorescence staining. C. elegans is a powerful model for eukaryotic genetic studies.
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They are the only animal for which the complete atlas of synaptic connectivity has been
mapped and the first multicellular organism with a complete genome sequence9,10.
In 2005, C. elegans neurons were excited with optogenetic manipulations for the
first time1. Since then, researchers have been using C. elegans to develop and test new
opsins. Even without optogenetic manipulations, C. elegans is sensitive to light. It
activates the GPCR photoreceptor and accelerates their locomotory rhythms as a response
to UV or blue light.
We report the discovery of a LITE-1 dependent behavioral response to Xradiation descriptively in the paper (1st author Kelli Cannon, University of Alabama at
Birmingham)11. In summary, to demonstrate the X-ray sensitivity of wild-type C.
elegans, we observed worm activity before (10 s) and after (10 s) exposure to X-rays.
The activity was measured in body area per minute using CeleST tracking software. After
X-ray exposure, the worms showed a robust increase in activity (locomotory rhythm) and
moved away from the X-ray beam spot. The X-ray dose-response was also monitored by
increasing the X-ray dose (0-1 Gy/s), which increased the worm activity as we increased
the X-ray dose. These results are similar to the response seen in wild-type C. elegans to
UV stimulation12. Then, to identify the photoreceptor (LITE-1 and, or GUR-3)
responsible for the behavior three mutant strains (dysfunctional LITE-1 (lite-1(ce314) X),
GUR-3 (gur-3(ok2245) X) and both LITE-1 and GUR-3 (lite-1(ce314) X gur-3(ok2245)
X)) were used with wild-type C. elegans and exposed to 1 Gy/s X-ray. GUR-3 muted
showed a significant increase in response to X-ray simulation similar to the wild-type
strain. LITE-1-muted strains showed a negligible increase in X-ray stimulation
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suggesting LITE-1 photoreceptor is responsible for X-ray stimulated behavior of C.
elegans.
Further, we show that LITE-1 can confer X-ray sensitivity when transgenically
expressed in otherwise X-ray insensitive cells. To determine LITE-1 can confer X-ray
sensitivity to X-ray insensitive cells pmyo-3::lite-1 C. elegans, which transgenically
express LITE-1 in myocytes, were used. The paralysis and egg ejection study using
pmyo-3::lite-1 showed induced paralysis and egg ejection. When exposed to X-ray,
induced paralysis and egg ejection were not observed in wild-type C. elegans. The
previous UV radiation studies show similar results in LITE-1 mediated muscle
contraction in pmyo-3::lite-18,12.
Our study is the first demonstration of X-ray mediated modulation of cellular
electrical activity that has similar functionality to optogenetics but with the advantage of
not delivering light via invasive optic fiber implants or RLPs. Here, we describe X-ray
stimulated egg ejection (ovulation) of C. elegans with transgenically expressed LITE-1
photoreceptor in X-ray insensitive body wall muscles (motor cells).

5.3. Methods
5.3.1. Growing, maintaining, and preparing C. elegans plates in the laboratory
C. elegans were grown on nematode growth media agar (NGM) plates. NGM agar
plates were prepared using commercially available NGM agar powder (Sigma-Aldrich)
NGM agar powder (5.75 g) was dispersed in 250 mL DI water. The mixture was heated
to dissolve completely and turned into a clear solution. Then, it was autoclaved at 121 °C
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(15 psi) for 20 mins. After autoclaving, it was kept to cool down to around 50 °C and
previously prepared (autoclaved), biological grade MgCl2 (1M, 250 M) and CaSO4 (1M,
250 M) were added. Then, Nystatin (5 mg/mL in ETOH, 500 uL), fungicide was added to
the prepared agar solution at around 37 °C and immediately poured into sterilized Petri
dishes.
After solidifying and cooling down to room temperature, OP50 E. coli were
inoculated using the spread plate method and incubated at 37 °C for overnight. E. coli
containing Petri plates were cooled down to room temperature to transfer C. elegans.
Then the worms were transferred using the “chuncking” technique wherein a sterilized
scalpel or spatula is used to move a chunk of agar (1 cm x 1 cm) from an old plate to a
fresh plate, as shown in Figure 5.1. (Worms were purchased from Carolina Biological
Supply and given by University of Alabama at Birmingham.)

Figure 5. 1: (A) Sterilizing a spatula by dipping in 70%ETOH and flaming. (B) Taking a 1 cm x 1
cm agar chunk from a NGM agar plate containing C. elegans. (C) transferring agar chunk into a
fresh plate with an E. coli lawn.
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5.3.2. Experiment setup
X-ray stimulation: X-rays were generated by a iMOXS-MFR W-target X-ray
unit with polycapillary optics (XOS) to focus the X-ray beam to a diameter of around
0.85 mm at the level of the agar surface, located approximately 5 cm from the tip of the
capillary attachment. The unit was operated at 50 kV, and the current was varied from 0
to 600 µA to achieve different stimulation intensities. A radiation dose of 1 Gy/s was
approximated at the highest intensity using RADSticker dosimeter stickers (JP
Laboratories, Inc.). An internal X-ray shutter was used to control the timing of the X-ray
stimulation.
Imaging Setup: A custom imaging setup was used to record worm egg ejection
responses to X-ray stimulation. Video data were recorded using an Amscope MU1003
10MP CMOS camera with a 0.7X-180X magnification lens. A white LED source
provided backlighting with a diffuser. The X-ray unit was mounted above the stage. The
stage was positioned using a motorized x-y translator controlled by the joystick of an
Xbox controller (Microsoft, Redmond WA). The entire imaging setup was enclosed in a
steel box with no detectable external X-ray leakage during use.
The irradiation zone was visualized using a piece of radiochromic film
(Gafchromic, XR-QA2) placed on the agar surface (see Figure 5.2 inset). The camera
recording software (Amscope 3.7) was used to annotate the video monitor with a circle
outlining the irradiation zone as visualized with the Gafchromic film for targeting
purposes.
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5.3.3. Egg ejection experiments
Experimental model: C. elegans roundworms (wild type N2 and Pmyo-3::lite-1
strains) were were used to study X-ray stimulated positive regulation of locomotory and
ovulation behavior. They were maintained at 22°C on nematode growth medium (NGM)
agar plates seeded with OP50 E. coli lawns (Brenner, 1974). The wild-type N2 strain was
used as a negative control. N2 nematodes were obtained from the Caehabditiris Genetics
Center, which is funded by the NIH Office of Research Infrastructure Programs (P40
OD010440). The lab of Dr. Shawn Xu generously provided Pmyo-3::lite-1 worms.
Experimental design: All experiments were conducted on OP50-lawned 100 mm
NGM plates inoculated with approximately 20-50 worms 72 hours prior. Looking at one
worm per trial, 40 trials were conducted on worms from 8 different plates, targeting 3 to
7 individual worms from each plate. As described above, for the avoidance experiments,
a piece of Gafchromic film was used to calibrate the location of the X-ray beam on the
agar surface. An adult hermaphrodite was selected, and the stage was moved to position
the worm in the center of the calibrated X-ray spot. Each trial began with 10 s during
which baseline behavior was recorded with the X-ray shutter closed. Then, the shutter
was opened to deliver a 15 s X-ray pulse. The responses of wild type and pmyo-3::lite-1
transgenic nematodes were tested at 0 and 1 Gy/s by applying 0 and 600 µA currents,
respectively, to the X-ray tube at a voltage of 50 kV. Ten trials at each of the two
intensities were conducted for each strain for 40 trials.
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5.4. Results and discussion
X-ray stimulated ovulation experiments were carried out in an in-house built
experiment set up (Figure 5.2). LED light source was used to illuminate the C. elegans
containing NGM agar plates. The plates are placed on the sample holder connected to a
motorized stage controlled by a joystick. The ovulation was video recorded using a
camera located under the sample holder and visualized using AmScope software on the
computer simultaneously. Prior to the X-ray exposure of C. elegans a Gafchromic film
was exposed. The spot size and the location were marked using AmScope software to
facilitate targeting the worms.

Figure 5. 2: (A) A Photograph (B)schematic diagram of the experimental setup. The schematic
diagram's right shows an X-ray spot visualized on a Grafchromic film and a worm targeted to Xray exposure.

Twenty worms from each strain (N2 and Pmyo-3::lite-1) were used in this
experiment. Figure 5.3 shows the MATLAB generated images of Pmyo-3::lite-1 and N2
strains 10s (A) before and (B) after the X-ray on. Before x-ray on worms showed no or
fewer movements, and the purple region in Figures 5.3A1 and B1 shows the total
movement during this period. After X-ray on, they show X-ray avoidance behavior in
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figure 5.3A2 and B2. Pmyo-3::lite-1 shows spastic motion/ less travel distance after Xray compared to N2.

Figure 5. 3: The behavior of Pmyo-3::lite-1 (A1) before X-ray on and (A2) after X-ray on. The
behavior of N2 (B1) before X-ray on and (B2) after X-ray on. The purple region corresponds to the
worm movement during 10s before or 10s after the X-ray on. Worm shape and location are
equivalent to the initial frame before or after the X-ray on.

Further, 50% (5 out of 10 worms) of Pmyo-3::lite-1 ejected eggs after X-ray on.
They started ejecting eggs in 3-5s after x-ray on and usually ejected 1-4 eggs during 15s
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exposure. Also, one worm ejected an egg immediately after the X-ray switched off (not
included in 50%). Figure 5.4 shows MATLAB generated images 1s before (Figure 5.4A)
and after (Figure 5.4B) ejecting an egg. The control N2 strain did not eject eggs when
exposed to X-ray. These results suggest that LITE-1 can function as an X-ray sensitive
receptor protein. It plays a critical role in the transduction of X-ray signals into ionic
currents and neural activity to produce behavioral responses.

Figure 5. 4: MATLAB generated an image of Pmyo-3::lite-1 1s before and after ejecting an egg.
The blue circle shows the ejected egg.
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Figure 5.5. shows the number of ejected eggs by each worm after an X-ray on.
The average number of ejected eggs is 1.10, and the standard deviation is 1.37. The
standard deviation is higher than the average number of ejected eggs as we consider 0-4
as the number of ejected eggs and used 10 worms for the experiment. Further, the N2
strain (more than 10 worms) did not eject eggs when exposed to X-ray.

Figure 5. 5: A graph of the number of eggs ejected after X-ray on vs. worm number (Pmyo-3::lite1).

The mechanisms by which X-ray activation of LITE-1 causes behavioral
responses are not yet known. Given the similarity between UV- and X-ray-induced
behaviors, it is reasonable to assume that the cellular and molecular pathways
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downstream of LITE-1 activation are the same, regardless of which type of radiation is
used to activate the receptor proteins.
5.5. Conclusions
In conclusion, we show that Wild type N2 nematodes avoid x-ray and pmyo3::lite-1 transgenic nematodes respond to X-ray. pmyo-3::lite-1 transgenic nematodes,
providing strong evidence that LITE-1 can function as an X-ray sensitive receptor in C.
elegans. This is the first demonstration of X-genetic control of cellular electrical activity
in intact, behaving animals. Future studies will reveal whether LITE-1 can enable
minimally invasive X-genetic neural control in mammalian animal models.
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CHAPTER SIX
SUMMARY AND FUTURE WORK
6.1. Introduction
This part of the dissertation summarizes the research projects discussed in
chapters two, three, and four and their future directions. Materials with at least one
dimension in the range of 1- 100 nm are considered to be nanoparticles, and they can
have interesting optical, magnetic, chemical, biological, or other properties compared to
their atomic levels and bulk materials. Also, compared to fluorescence dyes, they have a
large surface area where biomolecules can be attached and target biomarkers in vitro and
in vivo for bioimaging and sensing applications. Here, we are interested in studying the
optical properties of plasmonic and X-ray luminescence nanoparticles and their
applications in bioimaging and sensing.
In chapter two, light scattering due to LSPR of plasmonic nanoparticles was
studied. The size and shape of plasmonic nanoparticles (Au and Ag) were changed using
a mechanical force from ~90 nm to 180 nm and nanospheres to nanodiscs. The change in
the size/shape of plasmonic nanoparticles resulted in a red-shift in scattering spectra
compared to nanospheres. Another method was developed to prepare nanoparticle arrays
with shape tunned nanoparticles, and these nanoparticle patterns are visible under a dark
field microscope and to the naked eye. These nanoparticle arrays can be used in multidiagnostic platforms in the future. Like plasmonic nanoparticles, the optical properties of
X-ray luminescence nanoparticles were studied in chapter 3. X-ray luminescence
nanoparticles (~ 90-100 nm) were synthesized, and methods to enhance their optical

150

luminescence were studied in terms of the concentration of dopants and decreasing
crystal defects. Further, nanoparticles were used to obtain high-resolution optical images
through tissue. Finally, plasmonic and X-ray luminescence nanoparticles were used to
develop immunoassays, (1) a lateral flow assay to detect COVID-19 antibodies in human
saliva using AuNPs, and (2) a proof of concept to develop an implantable immunoassay
using combined optical properties of AuNPs and X-ray luminescence microparticles.
Chapter five includes a different research project. However, it is related to the
main theme as it uses X-rays and discusses sensing X-ray radiation. It is the discovery of
the LITE-1 photoreceptor of C. elegans sensitivity towards X-ray radiation. The X-ray
stimulated behavior of C. elegans shows X-ray avoidance behavior of wild-type N2 and
egg ejection of pmyo-3::lite-1 transgenic nematodes when exposed to X-ray.
The following sections (6.2-6.5) summary and future work of each chapter are
discussed.

6.2. Impressively printing patterns of gold and silver nanoparticles
In summary, chapter two presents the development of nanoimprint lithography
techniques that can be used to fabricate devices in biosensors, nanophotonic, etc. This
simple and robust technique uses a mechanical approach to change the shape of
plasmonic nanoparticles from nanospheres to nanodiscs and patterns them by placing
stamps. A glass rolling pin attached to a force gauge was rolled over plasmonic
nanoparticles coated glass slide to convert nanospheres to nanodiscs. A metal stamp or a
glucose deposit was placed on NPs before rolling to pattern them. The resulting
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nanoparticle shape change induces a red-shift in the localized surface plasmon resonance,
while regions untouched by the stamp remain unchanged. Further, it shows a simple
technique to transfer these patterns to a thin polymer film.
Nanorolls are produced using a slightly different approach (Figure 6.1B)
described in chapter two as a future direction. A glass slide attached to a force gauge was
slid on gold nanoparticles for this approach using shear to form “rolls” rather than simple
compression, which formed flattened “pancakes.” However, the yield of nanorolls is
meager; therefore, a more robust approach is required to increase the yield. During this
process, nanoparticle fusion was also observed, which is vital in making thin films,
studying nanoparticle growth mechanisms in synthesis, and optical properties during the
fusion.

Figure 6. 1: SEM images of Ag NPs (A) unrolled and (B) rolled AgNPs. (C) SEM image of fused
NPs during the deformation process

Although the research presented in this chapter shows a successful development
of the nanoimprint lithography technique, the question remains in terms of possible
applications. Our previous studies have proved an increase in surface area during the
deformation process; therefore, carrying out an investigation to study the surface area
increase by the crack formation, implementing catalytic/ enzymatic reactions, and
developing bioassays can be possible applications. As a preliminary study, color
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reduction of methyl orange was used in the presence of different sizes and concentrations
of AgNPs (Figure 6.2). The results show the increase in reaction rate with small-sized
particles due to the increase in the nanoparticle surface area.

Figure 6. 2: Methyl orange color reduction by NaBH4 using Ag NPs as a catalysts. (Ai-Ci) Negative
controls. (Aii) 10 minutes and (Aiii) 15 minutes after adding 200 µL of 1% (v/v) AgNPs. Five minutes
ofter adding (Bii) 200 µL and (Biii) 400 µL of 1% (v/v) AgNPs. Five minutes after adding 100 µL of
(Cii) 100 nm and (Biii) 50 nm of 1% (v/v) AgNPs.
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6.3. X-ray excited luminescence spectroscopy and imaging with NaGdF4:Eu and
Tb
Chapter three explains a study to synthesize, functionalize and characterize X-ray
luminescence nanoparticles. Also, a study was carried out to enhance the X-ray
luminescence intensity. The nanoparticles synthesized using the hydrothermal method
gave the highest luminescence intensity. Importantly, we selectively excited scintillator
nanophosphors using a focused X-ray source to generate light and collect them through
the tissue to generate high-resolution images, and XEOL was measured through tissue.
We also showed that the particles could serve as MRI contrast agents.
Another characteristic feature of these materials is that the elements in the
luminescence centers generate distinct spectra, and changing the host matrices creates a
small yet clear spectral shift. (Figure 6.3) The fine structure changes due to different
elements in the luminescence centers and host matrices can be observed under highresolution gratings. The spectral distinction is important in detecting, quantifying, and
imaging multiple biomarkers in vivo. Each type of nanoparticle can be functionalized
with a unique biomolecule to target multiple biomarkers. This also allows imaging the
distribution of target biomarkers locally using a focus X-ray beam.
Figures 6.3 A and B show the spectral differences between NaGdF4: Eu (10 mg)
and Gd2O2S: Eu (GOS:Eu, 1 mg). To show that we could distinguish each type of particle
in a mixture, we added NaGdF4 particles (10 mg) synthesized by the hydrothermal
method in chapter three in the presence of 1 mg of commercial 2.5 µm GOS:Eu particles
(UKL63/N-R1, Phosphor Technologies, Stevenage, England) and the X-ray
luminescence spectra were taken. We used a higher mass of NaGdF4 because it was less
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bright than GOS:Eu. X-ray excited optical luminescence intensity was collected
according to the procedure explained in chapter 3, section 3.3.9.

Figure 6. 3: (A) Low resolution and (B) High-resolution XEOL spectra from NaGdF4:Eu, Gd2O2S:Eu
and a mixture of both with spectrally distinct peaks.

From the spectra, we calculated the limit of detection (LOD) and quantification
(LOQ) of NaGdF4:Eu in the presence of Gd2O2S:Eu (1 mg) and vice versa (10 mg of
NaGdF4: Eu in Gd2O2S:Eu). To calculate the LOD and LOQ of NaGdF4:Eu (for both
simulation and experiment), X-ray luminescence spectra of Gd2O2S:Eu (1 mg) were
obtained 10 times, and the standard deviation (SD) of intensity ratios at 616/626
(wavelength) and 695/703 (wavelength) was calculated. (LOD= 3*SD/m, LOQ=
10*SD/m, where m is the slope of the calibration curve). To calculate the LOD and LOQ
of Gd2O2S:Eu (for both simulation and experiment), X-ray luminescence spectra of
NaGdF4:Eu (10 mg) were obtained 10 times, and the standard deviation (SD) of intensity
ratio at 626/616 (wavelength) and 703/695 (wavelength) was calculated. We note that
these calculations apply only to the experimental conditions tested, and that changes in
dose, optical collection efficiency and spectral resolution as well trial to trial sample

155

preparation will affect the values. Nonetheless, the studies do show that we can
distinguish and quantify low concentrations of one scintillator type in the presence of a
second scintillator, and the LOD provide estimates of where the signals become
significant compared to noise from the samples with only one particle type.
To set expectations, the spectra were simulated using experimental XEOL of
pure substances, NaGdF4: Eu (10 mg) and Gd2O2S: Eu (1mg). The intensity was
calculated at different weights (for NaGdF4:Eu: 0- 30 mg and GOS:Eu: 0- 0.256 mg) for
each substance. Then, the intensity ratio vs. weight graph was plotted (Figures 6.4 and
6.5, Ai and Aii) to determine the effect of the linear combination of pure substances. The
noise was calculated as the standard division of pure substances and expected LOD and
LOQ were calculated as explained above. According to the simulated data (Figure 6.4 Ai
and Aii), the limit of detection of NaGdF4:Eu is 0.56 mg at 616/626 (wavelength)
intensity ratio and 0.70 mg at 695/703 (wavelength) intensity. The limit of quantification
is 1.88 mg and 2.34 mg at 616/626 and 695/703 (wavelength) intensity ratio.
Figures 6.4 Bi and Bii plot the experimental spectra from varying amounts of
NaGdF4:Eu (0, 0.01, 0.04, 0.16, 0.64, 2.56 mg) added to a constant amount of GOS:Eu (1
mg). X-ray luminescence intensities were measured as explained in chapter 3, section
3.3.9. The experimental LOD of NaGdF4:Eu is 1.44 mg at 616/626 (wavelength) intensity
ratio and 1.42 mg at 695/703 (wavelength) intensity. The LOQ is 4.80 mg and 4.75 mg at
616/626 and 695/703 (wavelength) intensity ratio. The LODs at two wavelength ratios
are similar, and LOQs at two wavelength ratios are also similar. The slope and the
intercept values show reasonable concurrence between simulated and experiment data.
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The variation in LOD and LOQ in experimental and simulation data is mainly due to
variation in noise. It is due to variation in the weight range (simulated data 0-25 mg,
experimental data 0- 2.56 mg), sample preparation, and data collection.

Figure 6. 4: Calibration curve of (Ai) 616/626 nm intensity ratio and (Aii) 695/703 intensity ratio
vs weight of NaGdF4:Eu (mg) of simulated data. Calibration curve of (Bi) 616/626 nm intensity
ratio and (Bii) 695/703 intensity ratio vs weight of NaGdF4:Eu (mg) of experimented data.

Also, we calculated the LOD and LOQ of GOS:Eu in the presence of NaGdF4:Eu
(10 mg). first, the data were simulated using experimental XEOL of NaGdF4: Eu (10
mg), and the rest of the measurements and calculations were carried out as explained
above. According to the simulated data (Figure 6.5 Ai and Aii), the limit of detection of
GOS:Eu was 0.002 mg at 626/616 and 703/695 (wavelength) intensity ratios. The limit of
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quantification is 0.006 mg and 0.007 mg at 626/616 and 703/695 (wavelength) intensity
ratios.
To plot experimental data (Figures 6.5 Bi and Bii), varying amounts of GOS:Eu
(0, 0.01,0.02 0.04, 0.08, 0.16, 0.32, 0.64 mg) were added to a fixed amount of NaGdF4:
Eu (10 mg) and X-ray luminescence intensities and associated ratios were measured as
explained in chapter 3 section 3.3.9. The experimental LOD of GOS:Eu is 0.002 mg at
626/616 (wavelength) intensity ratio and 0.003 mg at 703/965 (wavelength) intensity.
The LOQ is 0.009 mg and 0.01 mg at 626/616 and 703/965 (wavelength) intensity ratios.
The experimental LOD and LOQ of NaGdF4: Eu is higher than GOS:Eu by a factor of
700 and 500, respectively, because GOS:Eu is brighter than NaGdF4: Eu. For both
NaGdF4: Eu and GOS:Eu, simulated LOD and LOQ are lower (better) than the
experimental values, the slopes were similar, and the worse experimental LODs and
LOQs were thus from more variation in experimental ratios at low GOS concentrations.
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Figure 6. 5: Calibration curve of (Ai) 626/616 intensity ratio and (Aii) 703/695 intensity ratio vs.
weight of NaGdF4:Eu (mg) of simulated data. Calibration curve of (Ai) 626/616 intensity ratio
and (Aii) 703/695 intensity ratio vs. weight of GOS:Eu (mg) of experimented data.

This preliminary study shows that the GOS:Eu and NaGdF4:Eu are spectrally

distinguished and potentially used in quantification applications. Further, GOS:Eu can be
detected at low concentrations (0.002-0.003 mg) against a large background of
NaGdF4:Eu (10 mg). Also, both the 620 and 700 nm peaks can be used with similar
LOD. Generally, the 620 peaks are brighter, but the 700 nm peaks penetrate through
thicker tissue. However, these results were only bulk spectral measurements, and further
studies are required before use in imaging applications.
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6.4. Functionalizing radiodense particles and developing immunoassays to detect
SARS-CoV-2 antibodies
In summary, chapter four discusses the development of two immunoassays. The
1st one is to develop an LFA using AuNPs to detect SARS-CoV-2 antibodies in human
saliva. The second is to build an implantable immunoassay using AuNPs and X-ray
luminescence microparticles. AuNPs and GOS:Eu microparticles were functionalized
with SARS-CoV-2 spike proteins and human anti-spike IgG. This chapter shows the
proof of concept of constructing both immunoassays. However, both immunoassays
require further development and statistical analysis regarding the limit of detection,
quantification, sensitivity, and specificity. Figure 6.6 shows the preliminary results of the
RBD protein depletion assay to confirm the protein binding to AuNPs further. However,
the assay was carried out in PBS buffer, resulting in the AuNPs flocculating and protein
attaching to the low protein binding vial wall. Therefore, this experiment needs to be
repeated in a different buffer like HEPES.

Figure 6. 6: (A) Schematic illustration of protein depletion assay. (B) UV-Vis spectra show λmax of
AuNPs after bioconjugation, RBD before, and after bioconjugation.
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6.5. X-ray stimulated egg ejection of C. elegans
Chapter five is related to the main theme as it uses X-rays and discusses sensing
of X-ray radiation by photoreceptors. It includes the discovery of the LITE-1
photoreceptor of C. elegans sensitivity towards X-ray radiation. When X-ray radiation is
focused onto wild-type N2, they avoid the X-ray beam, and pmyo-3::lite-1 transgenic C.
elegans eject eggs. As mentioned in chapter 5, C. elegans also show similar behavior
with UV and blue light. Therefore, in the future, we will study their behavior by inserting
X-ray luminescence nanoparticles into C. elegans and expect enhancement in their
response (Ex. fast movements and egg ejection compared to only X-ray stimulation). It
will also be interesting to distinguish the effect of increased X-ray absorption and photogenerated light by using luminescent particles with and without activator dopants to vary
light intensity without affecting X-ray absorption.

6.6. Conclusion
Nanomaterials are widely used in biomedical and other industries due to their
interesting optical and surface area that can be functionalized with biomolecules to target
biomarkers. This dissertation includes research work carried out to understand the
fundamental properties and biomedical applications of plasmonic and X-ray
luminescence nanoparticles. The research carried out to develop a mechanical method to
pattern nanoparticle arrays will open up new avenues to study the fundamental properties
of nanoparticle arrays with different shapes of nanoparticles. It also addresses one of the
limitations to transferring these nanoparticle arrays onto thin films that currently use high
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pressure and vacuum conditions. The X-ray luminescence nanoparticles synthesized
using the hydrothermal method agree with the previous studies, resulting in high
crystallinity and high X-ray luminescence. Further, thermal annealing can be used to
enhance the X-ray luminescence intensity of a nanoparticle. It also opens up a new
insight into changing the chemical structure of the lattice without changing the
nanoparticle's shape by thermal annealing. Finally, these plasmonic and X-ray
luminescence nanoparticles were used in developing immunoassays. The significance of
X-ray luminescence nanoparticles and gold nanoparticles combined assay will open up
new opportunities to build implantable immunoassays to detect analytes in vivo
continuously and locally. X-ray stimulated behavior of C. elegans is the discovery of the
sensitivity LITE-1 photoreceptor towards X-rays. Future studies will reveal whether
LITE-1 can enable minimally invasive X-genetic neural control in mammalian animal
models.
Overall, this dissertation shows the development of plasmonic and X-ray
luminescence nanoparticles in bioimaging and sensing applications. Although these two
nanoparticle systems have very different compositions and optical properties, they both
have properties that depend upon nano-domain photophysics. Especially, plasmonic
nanoparticles show LSPR when their size is large enough to free electron transport in the
metal but relatively small compared to the incident visible or near infrared light; and
bright X-ray luminescence nanoparticles can be achieved when domain size becomes
large relative to energetic photoelectron and exciton diffusion lengths. By controlling
nanoparticle size and or domain size, optical properties can be controlled and used for
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many biological applications, which also have size and surface chemistry-dependent
blood circulation and targeting properties. In the future, we hope to develop in vivo X-ray
luminescence immunoassays and bioimaging agents using antibody-antigen interactions
to coupling plasmonic and X-ray scintillating particles together with antigen dependent
gold nanoparticle attachment and associated luminescence quenching. Overall, such
nanomaterials have great promise for applications involving in situ sensing and highresolution imaging through tissue.
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Appendix A

APPENDICES

C. elegans x-ray avoidance behavior video analysis using MATLAB
cd('File location');
Ex: cd('D:\Research2\Spring 2020\C. elegans\N2 antioxidants\Control');
V1=VideoReader('Filename');
Ex:V1=VideoReader('N2C1.mp4');
numFrames = get(V1,'NumberOfFrames');
Number of frames, frame rate and other properties are located under “variablesV1”
I=read(V1,1);
1= 1st frame of the video
figure; imshow(I);
image of the 1st frame
Io01f1=read(V1,1);
Io01min(:,:)=Io01f1(:,:,3);
Minimum of the frame
Io01max(:,:)=Io01f1(:,:,3);
maximum of the frame
for i=1:260, Io01=read(V1,i); display(i);
Io01min(:,:)=min(Io01min,Io01(:,:,3));
Io01max(:,:)=max(Io01max ,Io01(:,:,3)); end;
I1colorb2=read(V1,1);
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I1colorb2(:,:,3)=I1colorb2(:,:,3) + 10*(Io01max-Io01min);
adding max minus min in blue
figure; imshow(I1colorb2);

Figure A-1: MATLAB image generated from (A) frame number 1 and (B) frame number 260 subtracted by
frame number 1.

I=read(V1,261);
figure; imshow(I);
Io01f1=read(V1,1);
Io01min(:,:)=Io01f1(:,:,3);
Io01max(:,:)=Io01f1(:,:,3);
for i=261:650, Io01=read(V1,i); display(i); Io01min(:,:)=min(Io01min,Io01(:,:,3));
Io01max(:,:)=max(Io01max ,Io01(:,:,3)); end;
I1colorb2=read(V1,261);
I1colorb2(:,:,3)=I1colorb2(:,:,3) + 10*(Io01max-Io01min);
figure; imshow(I1colorb2);
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Figure A-2: MATLAB image generated from (A) frame number 261 and (B) frame number 650 subtracted
by frame number 261
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Appendix B
Copyrights
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